[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"\"}":3,"_public_publisher_byId_83289c5a-0e1a-4089-90d0-8447ef02c8ba":656,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"totalCitation\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:83289c5a-0e1a-4089-90d0-8447ef02c8ba,\"}":671},{"meta":4,"data":6},{"total":5},"117",[7,60,176,207,299,413,445,480,543,572],{"id":8,"createTime":9,"updateTime":10,"relativeEntities":11,"slug":12,"properties":13,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":29,"subjectFields":30,"manageAffiliations":31,"indexDatabases":32,"url":33,"thumbnailPath":34,"statistic":35,"gsStatistic":26,"type":26,"analyzePriority":26},"5a09599f-54d1-44c3-8f16-3847ac552024","2023-08-17T04:28:50.832+00:00","2025-10-13T23:58:52.517+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Truy%E1%BB%81n-nhi%E1%BB%85m-Vi%E1%BB%87t-Nam",{"country":14,"issn":16,"introduce":18,"title":21},{"VOID":15},"VN",{"VOID":17},"08667829",{"EN":19,"VI":20},"{\"ops\":[{\"insert\":\"Vietnam Journal of Infectious Diseases is a social - professional forum of the Vietnam Society for Infectious Diseases, whose responsibility is to introduce the researches, the scientific advances in Vietnam and from the world; to contribute to the improvement of knowledges for health care staffs about clinic, treatment, guideline, prevention, epidemiology for infectious diseases, HIV\u002FAIDS and community health care; to provide, exchange and publish scientific information to the public accurately and promptly.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Vietnam Journal of Infectious Diseases publishes in the whole country; serves the professional work for researchers, clinical staffs, administrators, undergraduate and postgraduate students who are working and studying in the infections, tropical diseases and HIV\u002FAIDS from central to local levels, also organizations and individuals in the world who are interested in infectious and tropical diseases and prevention for HIV\u002FAIDS.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Editor in Chief:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Kinh. - Chairman of Editorial Board\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Mui.\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Headquarter:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Address:\"},{\"insert\":\" Level 6, National Hospital for Tropical Diseases, No. 78 Giai Phong Street, Dong Da District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tel:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913552672\"},\"insert\":\"0913552672\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"insert\":\".\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Bank account:\"},{\"insert\":\" 0021000275119, Vietcombank Hanoi Branch. Transaction office No. 7, 402 Tran Khat Chan, Hai Ba Trung District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Tạp chí Truyền nhiễm Việt Nam là cơ quan ngôn luận của Hội Truyền nhiễm Việt Nam, chịu sự lãnh đạo, chỉ đạo trực tiếp của Thường vụ Ban Chấp hành Hội Truyền nhiễm Việt Nam; sự kiểm tra, giám sát về nghiệp vụ báo chí của các cơ quan chức năng quản lý báo chí thuộc Bộ Thông tin và Truyền thông và Ban Tuyên giáo Trung ương Đảng.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí có trách nhiệm giới thiệu các công trình nghiên cứu khoa học, những tiến bộ khoa học trên thế giới và trong nước, góp phần nâng cao kiến thức khoa học cho cán bộ y tế về lâm sàng, điều trị, hướng dẫn, dự phòng, dịch tễ học các bệnh truyền nhiễm, HIV\u002FAIDS và chăm sóc sức khỏe cộng đồng; cung cấp, trao đổi, phổ biến các thông tin khoa học tới công chúng chính xác và kịp thời.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí xuất bản 03 tháng\u002F01 kỳ và được phát hành qua Bưu điện và tự phát hành trong phạm vi toàn quốc.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Lãnh đạo Tạp chí: \"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Tổng Biên tập: ThS.BSCKII Nguyễn Trung Cấp\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Phó Tổng Biên tập:\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"            TS.BSCKII Phạm Ngọc Thạch\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Trụ sở tòa soạn:\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Địa chỉ: Tầng 6, Bệnh viện Bệnh Nhiệt đới Trung ương, 78 đường Giải Phóng, phường Phương Mai, quận Đống Đa, thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Điện thoại:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\" - \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tài khoản:\"},{\"insert\":\" Số 0021000275119 Ngân hàng Ngoại thương Việt Nam, chi nhánh Hà Nội (Vietcombank Hà Nội). Phòng giao dịch số 7, 402 Trần Khát Chân, quận Hai Bà Trưng, Thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":22,"VI":23},"Vietnam Journal of Infectious Diseases","Tạp chí Truyền nhiễm Việt Nam","PUBLISHER","VERIFIED",null,"Admin update database","PENDING",51,[],[],[],"https:\u002F\u002Ftruyennhiemvietnam.vn\u002Findex.php\u002Fvjid","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F5a09599f-54d1-44c3-8f16-3847ac552024\u002Fadb0e52bf25e0de580fd4289519cb8bf.jpg",{"impactFactor":36,"impactFactorByYear":37,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":41,"totalPublicationByYear":42,"totalCitation":48,"totalCitationByYear":49,"totalCitationPerPublication":54,"totalCitationPerPublicationByYear":55,"hindexLast5Year":59,"hindex":59},0,{"2022":38,"2023":39,"2024":40},0.01,0.03,0.13,315,{"2020":43,"2021":44,"2022":45,"2023":46,"2024":47},63,58,57,65,72,43,{"2020":50,"2021":51,"2022":52,"2023":53},8,15,9,11,0.14,{"2020":40,"2021":56,"2022":57,"2023":58},0.26,0.16,0.17,3,{"id":61,"createTime":62,"updateTime":63,"relativeEntities":64,"slug":65,"properties":66,"entityType":24,"verifyStatus":25,"verifyTime":78,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":79,"subjectFields":80,"manageAffiliations":81,"indexDatabases":136,"url":137,"thumbnailPath":26,"statistic":138,"gsStatistic":155,"type":175,"analyzePriority":26},"25b6bd10-676c-40c0-8dc3-356d1679a284","2023-05-19T02:22:33.430+00:00","2026-06-18T23:33:57.141+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Y-D%C6%B0%E1%BB%A3c-h%E1%BB%8Dc-C%E1%BA%A7n-Th%C6%A1",{"country":67,"issn":68,"introduce":70,"title":73,"gsId":76},{"VOID":15},{"VOID":69},"23541210",{"EN":71,"VI":72},"\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">04\u002F10\u002F2015 Ministry of Information and Communications allowed Can Tho journal of medicine and pharmacy to operate (102 \u002FGP-BTTTT)\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">07\u002F16\u002F2015 Can Tho journal of medicine and pharmacy is internationally recognized: ISSN 2354-1210\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">In 2016, The journal has been included in the list of medical science journals by The State Council for professorship which is awarded a work score of 0-0.5 points for a published article.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Can Tho Journal of Medicine and Pharmacy welcome original works that haven’t been submitted or published in other medical journals. Posts must contain content related to one of the journal’s categories.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The content published\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The journal is divided into 3 categories:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Scientific research article: are valuable scientific works, which have been researched and accepted.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Overview of medicine, biology and pharmacy: serving the objective of continuing training in the fields of medicine, biology and pharmacy; to systematize classical and modern knowledge.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Update information on new knowledge about medicine, biology, pharmacy in the country and in the world.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Scope\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Publication and introduction of scientific research in the fields:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Medicine (internal medicine, surgery, pediatrics, obstetrics and gynecology, odonto-stomatology, laboratory, oncology, traditional medicine, nursing).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Biology (genetics, biotechnology).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Pharmacology (pharmaceutics, drug quality analysis-control, synthetic pharmaceutical chemistry, biochemistry, pharmacognosy, botany, clinical pharmacy).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- To enhance the quality of undergraduate, postgraduate education, scientifically researching and meet the necessary treatment in hospital.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Introducing the updated domestic and oversea information about science technology to promote scientific research and exchanging technology in local, other universities.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Exchanging pharmaceutical and medical information for social health developing in the Mekong Delta and Vietnam.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The object\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Postgraduate students, student of Can Tho University of Medicine and Pharmacy, scientists from schools, research institutes, hospitals, health centers, pharmaceutical companies of the Mekong Delta; other provinces and regions in Vietnam and other country.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Address\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Headquarters of Can Tho Journal of Medicine and Pharmacy, located Scientific Research and International Cooperation Office: 179 Nguyen Van Cu Street, An Khanh Ward, Ninh Kieu District, Can Tho City, Vietnam.\u003C\u002Fspan>\u003C\u002Fp>","\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Ngày 16\u002F7\u002F2015, Tạp chí Y Dược học Cần Thơ được cấp chỉ số quốc tế: ISSN 2354-1210.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 4\u002F2016, Tạp chí đã được Hội đồng Giáo sư ngành Y đưa vào danh sách các tạp chí khoa học Y học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Năm 2020 Tạp chí Y Dược học Cần Thơ đã được phê duyệt vào danh mục của các Hội đồng Giáo sư ngành Dược học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ ra 12 số\u002Fnăm, 180-200 trang\u002Fsố.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 12\u002F2022 Tạp chí Y Dược học Cần Thơ là thành viên của hệ thống Crossref và từ tháng 01\u002F2023 tạp chí thực hiện bình duyệt online kín 2 chiều nhằm tăng tính minh bạch, tin cậy của các công trình nghiên cứu khoa học và đảm bảo tốt nhất chất lượng khoa học của bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ, mục đích và phạm vi của tạp chí\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ và mục đích hoạt động của tạp chí: xuất bản nhằm mục đích phổ biến kết quả từ các đề tài nghiên cứu khoa học; giao lưu trao đổi khoa học, chia sẻ kinh nghiệm, học tập, đồng thời cập nhật thông tin khoa học mới trong các lĩnh vực y, sinh, dược học trong và ngoài nước.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phạm vi của tạp chí: Tạp chí xuất bản được chia thành 3 chuyên mục: (i) Bài báo nghiên cứu khoa học là kết quả công trình nghiên cứu khoa học có giá trị đã được triển khai nghiên cứu, (ii) Bài tổng quan y, sinh, dược học: phục vụ mục tiêu đào tạo liên tục trong lĩnh vực y, sinh, dược học; nhằm hệ thống hóa những kiến thức kinh điển và hiện đại; (iii) Thông tin cập nhật kiến thức mới về y, sinh, dược học trong nước và trên thế giới.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Chính sách truy cập mở\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ áp dụng chính sách truy cập mở đối với các bài báo đã xuất bản đến với độc giả, nhằm mở rộng cơ hội tiếp cận các kết quả nghiên cứu chất lượng cao và tăng cường trao đổi kiến thức. Tạp chí đăng tải trực tuyến (miễn phí) toàn văn các bài báo được công bố trên website của Tạp chí (https:\u002F\u002Ftapchi.ctump.edu.vn).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đạo đức xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ cam kết tuân thủ đạo đức xuất bản phù hợp với các hướng dẫn và tiêu chuẩn của the Committee on Publication Ethics (COPE), tuân thủ các nguyên tắc của COPE’s Core Practices, Best Practices Guidelines for Journal Editors và Guidelines on Good Publication Practices.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Bản thảo bài báo chỉ được chấp nhận khi được tác giả chịu trách nhiệm chính cam kết các nội dung sau: Các nội dung của bản thảo chưa được đăng tải toàn bộ hoặc một phần ở các tạp chí khác; Tất cả các tác giả đều có đóng góp một cách đáng kể vào quá trình nghiên cứu hoặc chuẩn bị bản thảo và cùng chịu trách nhiệm về các nội dung của bản thảo; Tuân thủ các biện pháp đảm bảo đạo đức nghiên cứu (ví dụ thỏa thuận đồng ý tham gia nghiên cứu).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Cam kết bảo mật\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí cam kết thực hiện và tuân thủ các quy định của luật và các văn bản hướng dẫn liên quan đến bảo mật thông tin cá nhân trên không gian mạng. Các thông tin mà người dùng (tác giả, độc giả, biên tập viên, người phản biện) nhập vào các biểu mẫu trên Hệ thống Quản lý xuất bản trực tuyến của tạp chí chỉ được sử dụng vào các mục đích đã được tuyên bố rõ ràng và sẽ không được cung cấp cho bất kỳ bên thứ ba nào khác, hay dùng vào bất kỳ mục đích nào khác.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phí gửi bài\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng bài: 1.000.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng nhanh: 1.500.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với tác giả là cán bộ viên chức thuộc Trường Đại học Y Dược Cần Thơ thì được hỗ trợ 50% lệ phí gửi đăng bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với sinh viên thực hiện đề tài nghiên cứu khoa học cấp trường được hỗ trợ 100% lệ phí đăng bài ( Tác giả gửi đính kèm “ Quyết định về việc giao tổ chức thực hiện đề tài nghiên cứu khoa học cấp Trường của sinh viên”).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Hình thức nộp lệ phí:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Tiền mặt:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Nộp trực tiếp tại Phòng Tài chính - Kế toán, Trường Đại học Y Dược Cần Thơ, số 179 Nguyễn Văn Cừ, P. An Khánh, Q. Ninh Kiều, thành phố Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Chuyển khoản:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tên Tài khoản: Trường ĐHYD Cần Thơ, Số TK: 0111000115668, tại ngân hàng Vietcombank chi nhánh Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Thời gian: Áp dụng từ ngày 01\u002F02\u002F2023.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">* Phí gửi bài không được hoàn trả khi bài viết bị từ chối hoặc tác giả xin rút bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Quy trình phản biện bài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ thực hiện quy trình phản biện kín hai chiều nghiêm ngặt. Danh tính của những người phản biện không được tiết lộ cho các tác giả và ngược lại. Quy trình thẩm định bài báo đăng gồm các bước sau:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tiếp nhận bản thảo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tác giả liên hệ gửi bản thảo đến Tạp chí qua hệ thống trực tuyến tại website: https:\u002F\u002Ftapchi.ctump.edu.vn. Hướng dẫn về cách đăng ký, gửi bài và chuẩn bị bản thảo được cung cấp trên website của Tạp chí.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sàng lọc sơ bộ\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sau khi Tòa soạn nhận được bài báo của tác giả, Ban Thư ký sẽ tiến hành kiểm tra sơ bộ bài báo (các yêu cầu về nội dung và hình thức). Những bài báo không đúng quy cách hoặc có nội dung không phù hợp hoặc vi phạm bản quyền sẽ bị từ chối (Ban Thư ký thông báo phản hồi đến tác giả trong vòng 1 tuần). Những bài báo đủ điều kiện, được Ban Thư ký tòa soạn chuyển đến Ban Biên tập có cùng chuyên môn với nội dung bài báo để đề xuất người phản biện. Thời gian kể từ khi Ban Biên tập nhận bài báo đến khi đề xuất người phản biện bài báo chậm nhất là 5 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Vòng phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký gửi bài và yêu cầu phản biện đến 02 phản biện độc lập.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Các phản biện gởi nhận xét cho Ban Thư ký. Thời gian từ khi gửi bài cho phản biện đến khi nhận ý kiến của phản biện tối đa là 20 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xử ký kết quả phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Nếu ý kiến đồng ý cho đăng và không cần chỉnh sửa, Ban Thư ký tiếp tục đăng bài theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Nếu ý kiến đồng ý đăng và cần chỉnh sửa, Ban Thư ký sẽ thông tin đến tác giả chỉnh sửa theo yêu cầu của người phản biện. Thời gian chỉnh sửa và gửi lại kéo dài không quá 2 tuần, từ khi tác giả bài báo nhận được thông tin (Quá trình này có thể lặp lại tối đa 2 lần\u002F1 bài báo). Khi có sự thống nhất, đồng ý của người phản biện; bài báo được tiếp tục đăng theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Những bài báo có chất lượng không đạt yêu cầu, cả 2 phản biện không đồng ý cho đăng sẽ bị Tòa soạn từ chối đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký tổng hợp các bản thảo đã được tác giả hoàn thiện sau thẩm định trình Ban Biên tập xem xét, Tổng Biên tập phê duyệt, quyết định bài đăng theo các tiêu chí: sự phù hợp nội dung với tôn chỉ và mục đích, thể loại bài viết (ưu tiên các bài có bài có nghiên cứu chuyên sâu, hàm lượng khoa học cao), đóng góp mới bài báo, bài báo được ưu tiên đăng trong số gần nhất của Tạp chí theo thứ tự: tính thời sự, chất lượng bài báo và thời gian gửi bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Ban Biên tập và Ban Thư ký biên tập bản thảo, chế bản, đọc rà soát lỗi. Thời gian hoàn thành từ 10-15 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Ban Thư ký có trách nhiệm thông báo cho tác giả bài báo (bằng e-mail) về tình hình phê duyệt bài báo, thời gian, số kỳ, tập xuất bản bài báo theo qui định.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">4. Danh sách bài báo theo số Tạp chí được in ấn và phát hành trong năm định kỳ được công bố chính thức trên website: https:\u002F\u002Ftapchi.ctump.edu.vn\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>",{"EN":74,"VI":75},"Cantho Journal of Medicine and Pharmacy","Tạp chí Y Dược học Cần Thơ",{"VOID":77},"wcQ1uqwAAAAJ","2023-05-30T08:17:21.868+00:00",32,[],[82],{"id":83,"createTime":84,"updateTime":85,"relativeEntities":86,"slug":87,"properties":88,"entityType":98,"verifyStatus":25,"verifyTime":99,"verifyNote":26,"syncStatus":28,"languages":100,"translateLanguages":26,"viewCount":103,"url":104,"parentIds":105,"statistic":106},"6413896b-eca9-442b-a73f-182a58a0ce40","2023-06-12T14:59:13.446+00:00","2026-06-19T02:29:32.871+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Y-D%C6%B0%E1%BB%A3c-C%E1%BA%A7n-Th%C6%A1",{"country":89,"title":90,"address":93,"abbreviation":96},{"VOID":15},{"EN":91,"VI":92},"Can Tho University of Medicine and Pharmacy","Trường Đại học Y Dược Cần Thơ",{"VI":94,"EN":95},"Số 179, đường Nguyễn Văn Cừ, phường An Khánh, quận Ninh Kiều, thành phố Cần Thơ, Việt Nam","No 179, Nguyen Van Cu street, An Khanh ward, Ninh Kieu district, Can Tho city, Vietnam",{"VOID":97},"ctump","AFFILIATION","2023-08-01T14:07:27.977+00:00",[101,102],"VI","EN",12,"http:\u002F\u002Fwww.ctump.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":107,"i10Index":111,"i10IndexLast5Year":59,"totalPublication":112,"totalPublicationByYear":113,"totalCitation":122,"totalCitationByYear":123,"totalCitationPerPublication":128,"totalCitationPerPublicationByYear":129,"hindexLast5Year":135,"hindex":135},{"2022":108,"2023":109,"2024":110,"2025":38},0.1,0.05,0.07,4,1489,{"2013":114,"2014":115,"2015":115,"2016":111,"2017":115,"2018":59,"2019":114,"2020":116,"2021":117,"2022":118,"2023":119,"2024":120,"2025":121,"2026":111},2,1,10,84,281,680,260,156,313,{"2013":59,"2014":114,"2018":124,"2021":125,"2022":126,"2023":127},17,36,123,132,0.21,{"2013":130,"2014":114,"2018":131,"2021":132,"2022":133,"2023":134},1.5,5.67,0.43,0.44,0.19,6,[],"https:\u002F\u002Ftapchi.ctump.edu.vn\u002Findex.php\u002Fctump",{"impactFactor":36,"impactFactorByYear":139,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":140,"totalPublicationByYear":141,"totalCitation":147,"totalCitationByYear":148,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":152,"hindexLast5Year":135,"hindex":135},{"2022":38,"2023":36,"2024":39,"2025":38},1956,{"0":114,"2019":114,"2020":50,"2021":142,"2022":143,"2023":144,"2024":145,"2025":146},76,403,789,305,371,524,{"0":114,"2019":135,"2021":124,"2022":149,"2023":150,"2024":111,"2025":114},287,206,0.27,{"0":115,"2019":59,"2021":153,"2022":154,"2023":56,"2024":38,"2025":38},0.22,0.71,{"impactFactor":26,"impactFactorByYear":26,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":156,"totalPublicationByYear":157,"totalCitation":163,"totalCitationByYear":164,"totalCitationPerPublication":169,"totalCitationPerPublicationByYear":170,"hindexLast5Year":135,"hindex":135},461,{"0":158,"2019":114,"2021":159,"2022":160,"2023":161,"2024":158,"2025":162},7,37,296,107,5,419,{"2021":59,"2022":59,"2023":165,"2024":166,"2025":167,"2026":168},71,126,171,41,0.91,{"2021":171,"2022":38,"2023":172,"2024":173,"2025":174},0.08,0.66,18,34.2,"JOURNAL",{"id":177,"createTime":178,"updateTime":179,"relativeEntities":180,"slug":181,"properties":182,"entityType":24,"verifyStatus":25,"verifyTime":193,"verifyNote":26,"syncStatus":28,"languages":194,"translateLanguages":26,"viewCount":36,"subjectFields":195,"manageAffiliations":196,"indexDatabases":197,"url":198,"thumbnailPath":26,"statistic":26,"gsStatistic":199,"type":175,"analyzePriority":26},"f8d0bf97-8d89-482e-b58c-2fc481a0b79b","2025-10-27T06:27:08.591+00:00","2026-06-18T23:33:41.667+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-v%C3%A0-C%C3%B4ng-ngh%E1%BB%87-nhi%E1%BB%87t-%C4%91%E1%BB%9Bi",{"country":183,"introduce":184,"gsId":186,"title":188,"issn":191},{"VOID":15},{"EN":185},"\u003Cp style=\"text-align:justify;\">     Journal of Tropical Science and Engineering (JTSE) is a multidisciplinary scientific journal, licensed to operate as a print journal in 2012 and an electronic journal in 2024 (License No.1479\u002FGP-BTTTT dated August 20, 2012 and No.91\u002FGP-BTTTT dated April 9, 2024 issued by the Ministry of Information and Communications of Vietnam). The JTSE is headquartered in Hanoi.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">        The JTSE is published every 3 months (4 issues\u002Fyear), publishing research results and overview articles in 3 groups of fields: Tropical Ecology and Environment; Chemistry and Material Sciences; Biomedicine and Pharmacy. In 2022, the JTSE registered the international identifier Digital Object Identifier (DOI): 10.58334\u002Fvrtc.jtst and assigned DOI codes to all articles of the journal. The members of the Editorial Board of the JTSE are prestigious scientists and leading scientists from Vietnam and many countries in the world. The JTSE has been recognized by the Vietnam State Council for Professorship to score scientific articles in Chemistry, Medicine and Biology with scores ranging from 0-0.75 points.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">      Currently, the JTSE is building and perfecting a set of criteria and making efforts to join the List of prestigious  international journals with a roadmap to enter Scopus and SCIE in the coming time.\u003C\u002Fp>",{"VOID":187},"MS2_GJQAAAAJ",{"VI":189,"EN":190},"Tạp chí Khoa học và Công nghệ nhiệt đới","Journal of Tropical Science and Engineering",{"VOID":192},"08667535","2025-10-27T06:27:25.058+00:00",[101,102],[],[],[],"https:\u002F\u002Ftapchikhcnnd.com.vn",{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":200,"totalPublicationByYear":201,"totalCitation":161,"totalCitationByYear":203,"totalCitationPerPublication":153,"totalCitationPerPublicationByYear":205,"hindexLast5Year":114,"hindex":114},481,{"0":115,"2020":115,"2021":115,"2022":114,"2024":115,"2025":202,"2026":115},474,{"2017":114,"2018":115,"2019":111,"2020":162,"2021":162,"2022":116,"2023":50,"2024":162,"2025":204,"2026":52},52,{"2020":162,"2021":162,"2022":162,"2024":162,"2025":206,"2026":52},0.11,{"id":208,"createTime":209,"updateTime":210,"relativeEntities":211,"slug":212,"properties":213,"entityType":24,"verifyStatus":25,"verifyTime":221,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"subjectFields":223,"manageAffiliations":224,"indexDatabases":225,"url":226,"thumbnailPath":26,"statistic":227,"gsStatistic":276,"type":175,"analyzePriority":26},"a3d1e82a-57e2-40f9-940e-f5fa8b9ef64a","2023-06-01T07:11:26.039+00:00","2026-06-18T23:33:28.573+00:00",[],"VNU-Journal-of-Science-Earth-and-Environmental-Sciences",{"issn":214,"title":216,"country":218,"gsId":219},{"VOID":215},"26159279",{"EN":217},"VNU Journal of Science: Earth and Environmental Sciences",{"VOID":15},{"VOID":220},"UmXD8vEAAAAJ","2023-06-01T07:17:59.210+00:00",27,[],[],[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FEES",{"impactFactor":36,"impactFactorByYear":228,"i10Index":234,"i10IndexLast5Year":36,"totalPublication":235,"totalPublicationByYear":236,"totalCitation":246,"totalCitationByYear":247,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":262,"hindexLast5Year":103,"hindex":103},{"2010":229,"2012":40,"2013":230,"2014":230,"2015":231,"2016":54,"2017":171,"2018":109,"2019":110,"2020":57,"2021":232,"2022":233,"2023":151,"2024":58},0.02,0.04,0.09,0.31,0.4,19,656,{"2008":237,"2009":238,"2010":239,"2011":238,"2012":240,"2013":241,"2014":239,"2015":242,"2016":243,"2017":244,"2018":245,"2019":165,"2020":125,"2021":168,"2022":125,"2023":222,"2024":111},23,24,22,28,25,20,146,29,78,1038,{"2008":248,"2009":249,"2010":250,"2011":251,"2012":252,"2013":253,"2014":254,"2015":255,"2016":256,"2017":257,"2018":161,"2019":258,"2020":259,"2021":29,"2022":260},119,64,66,86,38,73,59,31,129,39,97,53,26,1.58,{"2008":263,"2009":264,"2010":59,"2011":265,"2012":266,"2013":267,"2014":268,"2015":269,"2016":270,"2017":271,"2018":272,"2019":272,"2020":273,"2021":274,"2022":275},5.17,2.67,3.58,1.36,2.92,2.68,1.55,0.88,1.34,1.37,1.47,1.24,0.72,{"impactFactor":26,"impactFactorByYear":26,"i10Index":173,"i10IndexLast5Year":135,"totalPublication":277,"totalPublicationByYear":278,"totalCitation":279,"totalCitationByYear":280,"totalCitationPerPublication":288,"totalCitationPerPublicationByYear":289,"hindexLast5Year":158,"hindex":298},113,{"2007":114,"2008":103,"2009":173,"2010":116,"2011":51,"2012":239,"2013":103,"2014":162,"2015":53,"2016":135},616,{"2009":162,"2010":114,"2011":52,"2012":124,"2013":222,"2014":255,"2015":48,"2016":44,"2017":281,"2018":282,"2019":259,"2020":283,"2021":284,"2022":285,"2023":286,"2024":257,"2025":287,"2026":59},54,60,49,47,34,44,33,5.45,{"2009":290,"2010":291,"2011":292,"2012":293,"2013":294,"2014":295,"2015":296,"2016":297},0.28,0.2,0.6,0.77,2.25,6.2,3.91,9.67,14,{"id":300,"createTime":301,"updateTime":302,"relativeEntities":303,"slug":304,"properties":305,"entityType":24,"verifyStatus":25,"verifyTime":316,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":234,"subjectFields":317,"manageAffiliations":318,"indexDatabases":388,"url":389,"thumbnailPath":390,"statistic":391,"gsStatistic":409,"type":175,"analyzePriority":26},"a7166325-6c9e-4db3-8a59-7c879701a372","2023-07-31T04:28:49.231+00:00","2026-06-18T23:33:22.428+00:00",[],"VNU-Journal-of-Science-Policy-and-Management-Studies",{"country":306,"issn":307,"eissn":309,"title":311,"gsId":314},{"VOID":15},{"VOID":308},"26159295",{"VOID":310},"25881116",{"EN":312,"VI":313},"VNU Journal of Science: Policy and Management Studies","Tạp chí Nghiên cứu Chính sách và Quản lý",{"VOID":315},"xKW2E_cAAAAJ","2023-08-01T03:23:46.688+00:00",[],[319],{"id":320,"createTime":321,"updateTime":322,"relativeEntities":323,"slug":324,"properties":325,"entityType":98,"verifyStatus":25,"verifyTime":335,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":336,"url":337,"parentIds":338,"statistic":339},"12466116-8f60-4b01-8faf-2411483a0977","2023-05-30T09:37:38.472+00:00","2026-06-19T02:14:28.352+00:00",[],"Vietnam-National-University",{"country":326,"title":327,"abbreviation":330,"address":332},{"VOID":15},{"EN":328,"VI":329},"Vietnam National University, Hanoi","Đại học Quốc gia Hà Nội",{"VOID":331},"VNU",{"VI":333,"EN":334},"Số 144 Xuân Thủy, Phường Dịch Vọng Hậu, Quận Cầu Giấy, Hà Nội, Việt Nam","No. 144 Xuan Thuy Street, Dich Vong Hau Ward, Cau Giay District, Hanoi, Vietnam","2023-08-02T13:58:17.029+00:00",16,"http:\u002F\u002Fwww.vnu.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":340,"i10Index":285,"i10IndexLast5Year":162,"totalPublication":344,"totalPublicationByYear":345,"totalCitation":354,"totalCitationByYear":355,"totalCitationPerPublication":368,"totalCitationPerPublicationByYear":369,"hindexLast5Year":336,"hindex":336},{"2014":109,"2015":231,"2016":231,"2017":206,"2018":341,"2019":110,"2020":342,"2021":343,"2022":171,"2023":231,"2024":110,"2025":39},0.06,0.18,0.35,1247,{"2003":115,"2004":115,"2005":114,"2006":59,"2007":111,"2008":162,"2009":59,"2010":50,"2011":124,"2012":336,"2013":260,"2014":244,"2015":250,"2016":281,"2017":346,"2018":347,"2019":348,"2020":349,"2021":350,"2022":351,"2023":352,"2024":353,"2025":255,"2026":50},94,88,83,67,176,185,187,93,1644,{"2004":111,"2005":115,"2006":52,"2007":298,"2008":356,"2009":298,"2010":286,"2011":357,"2012":244,"2013":358,"2014":359,"2015":360,"2016":361,"2017":362,"2018":363,"2019":364,"2020":365,"2021":366,"2022":367,"2023":367,"2024":162},13,81,48,70,151,115,109,259,174,181,121,101,1.32,{"2004":111,"2005":370,"2006":59,"2007":371,"2008":372,"2009":373,"2010":374,"2011":375,"2012":376,"2013":377,"2014":378,"2015":379,"2016":380,"2017":381,"2018":382,"2019":383,"2020":384,"2021":385,"2022":386,"2023":387,"2024":109},0.5,3.5,2.6,4.67,5.5,4.76,1.81,1.85,2.41,2.29,2.13,1.16,2.94,2.1,2.7,0.69,0.55,0.54,[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FPaM","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002Fa7166325-6c9e-4db3-8a59-7c879701a372\u002Fecfe83f4bcc60c7023ae04d8900fe0ac.jpg",{"impactFactor":36,"impactFactorByYear":392,"i10Index":111,"i10IndexLast5Year":36,"totalPublication":394,"totalPublicationByYear":395,"totalCitation":399,"totalCitationByYear":400,"totalCitationPerPublication":293,"totalCitationPerPublicationByYear":403,"hindexLast5Year":158,"hindex":158},{"2018":109,"2019":171,"2020":393,"2021":108,"2022":54,"2023":206,"2024":54},0.23,320,{"2015":50,"2016":239,"2017":286,"2018":396,"2019":397,"2020":159,"2021":398,"2022":168,"2023":79,"2024":255},30,35,40,247,{"2015":115,"2016":242,"2017":401,"2018":222,"2019":402,"2020":79,"2021":239,"2022":50,"2023":116},77,50,{"2015":404,"2016":169,"2017":405,"2018":406,"2019":407,"2020":408,"2021":386,"2022":291,"2023":232},0.12,1.75,0.9,1.43,0.86,{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":103,"totalPublicationByYear":410,"totalCitation":234,"totalCitationByYear":411,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":412,"hindexLast5Year":114,"hindex":59},{"2015":114,"2016":116},{"2016":115,"2017":114,"2018":114,"2019":59,"2020":114,"2021":59,"2022":114,"2023":114,"2024":115,"2026":115},{"2016":108},{"id":414,"createTime":415,"updateTime":416,"relativeEntities":417,"slug":418,"properties":419,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":238,"subjectFields":428,"manageAffiliations":429,"indexDatabases":430,"url":431,"thumbnailPath":26,"statistic":432,"gsStatistic":438,"type":175,"analyzePriority":26},"16e65a3f-d274-47dd-8691-56d76eb58c3d","2023-05-30T09:10:06.062+00:00","2026-06-18T23:33:17.679+00:00",[],"Vietnam-Journal-of-Otorhinolaryngology-Head-and-Neck-Surgery",{"country":420,"issn":421,"title":423,"gsId":426},{"VOID":15},{"VOID":422},"18593704",{"EN":424,"VI":425},"Vietnam Journal of Otorhinolaryngology - Head and Neck Surgery","Tạp chí Tai Mũi Họng Việt Nam",{"VOID":427},"L78B_eIAAAAJ",[],[],[],"https:\u002F\u002Ftapchitaimuihong.vn\u002Findex.php\u002Ftmh",{"impactFactor":36,"impactFactorByYear":433,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":434,"totalPublicationByYear":435,"totalCitation":111,"totalCitationByYear":436,"totalCitationPerPublication":230,"totalCitationPerPublicationByYear":437,"hindexLast5Year":115,"hindex":115},{"2024":229},95,{"2022":52,"2023":286,"2024":255,"2025":53},{"2023":111},{"2023":231},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":240,"totalPublicationByYear":439,"totalCitation":234,"totalCitationByYear":440,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":442,"hindexLast5Year":114,"hindex":114},{"2023":53,"2024":116,"2025":135,"2026":115},{"2024":59,"2025":298,"2026":114},0.68,{"2024":443,"2025":444,"2026":114},0.3,2.33,{"id":446,"createTime":447,"updateTime":448,"relativeEntities":449,"slug":450,"properties":451,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":396,"subjectFields":460,"manageAffiliations":461,"indexDatabases":462,"url":463,"thumbnailPath":464,"statistic":465,"gsStatistic":472,"type":175,"analyzePriority":26},"25988add-c322-4eda-afda-63b1559bb824","2023-04-07T03:49:55.817+00:00","2026-06-18T23:32:23.776+00:00",[],"T%E1%BA%A1p%20ch%C3%AD%20Y%20-%20D%C6%B0%E1%BB%A3c%20h%E1%BB%8Dc%20qu%C3%A2n%20s%E1%BB%B1",{"country":452,"issn":453,"title":455,"gsId":458},{"VOID":15},{"VOID":454},"18590748",{"EN":456,"VI":457},"Journal of Military Pharmaco-medicine","Tạp chí Y - Dược học quân sự",{"VOID":459},"_pmQ8IEAAAAJ",[],[],[],"https:\u002F\u002Fjmpm.vn\u002Findex.php\u002Fjmpm","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F25988add-c322-4eda-afda-63b1559bb824\u002F09c6bc42157cf5ece95edc971ccddb52.jpg",{"impactFactor":36,"impactFactorByYear":466,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":467,"totalPublicationByYear":468,"totalCitation":135,"totalCitationByYear":470,"totalCitationPerPublication":38,"totalCitationPerPublicationByYear":471,"hindexLast5Year":115,"hindex":115},{"2023":229,"2024":38},475,{"2022":168,"2023":365,"2024":469,"2025":124},236,{"2022":114,"2023":111},{"2022":109,"2023":229},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":277,"totalPublicationByYear":473,"totalCitation":401,"totalCitationByYear":474,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":475,"hindexLast5Year":59,"hindex":59},{"2015":115,"2018":114,"2019":115,"2020":115,"2021":59,"2022":103,"2023":159,"2024":287,"2025":237},{"2020":115,"2021":115,"2022":115,"2023":52,"2024":237,"2025":79,"2026":116},{"2020":115,"2021":476,"2022":171,"2023":477,"2024":478,"2025":479},0.33,0.24,0.7,1.39,{"id":481,"createTime":482,"updateTime":483,"relativeEntities":484,"slug":485,"properties":486,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":496,"translateLanguages":26,"viewCount":45,"subjectFields":497,"manageAffiliations":498,"indexDatabases":525,"url":526,"thumbnailPath":527,"statistic":528,"gsStatistic":26,"type":26,"analyzePriority":26},"2b8d7b12-2d20-4777-be98-077f44f03c69","2023-09-07T07:40:58.286+00:00","2025-07-13T21:21:00.542+00:00",[],"VNU-Journal-of-Social-Sciences-and-Humanities",{"country":487,"issn":488,"introduce":490,"title":493},{"VOID":15},{"VOID":489},"23541172",{"EN":491,"VI":492},"{\"ops\":[{\"insert\":\"VNU Journal of Social Sciences and Humanities (ISSN 2354-1172) is a double-blind peer-reviewed journal published by University of Social Sciences and Humanities, Vietnam National University, Hanoi, Vietnam, under the publication permit no. 155\u002FGP-BTTTT, issued on 11\"},{\"attributes\":{\"script\":\"super\"},\"insert\":\"th \"},{\"insert\":\"May, 2015 by Ministry of Information and Communications. The journal publishes four Vietnamese issues and two English issues per year.\\nCurrently, there are 35 reputable professors in the editorial board. The main objectives of the journal include: providing an intellectual platform for Vietnamese and international scholars; promoting interdisciplinary studies in social sciences and humanities; becoming the leading journal in social sciences and humanities in Vietnam; being indexed by worldwide databases and having academic recognition internationally in the near future.\\nThe journal is currently indexed by Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services and Vietnam National University’s digital archive.\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Journal of Social Sciences and Humanities-Vietnam\"},{\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"ISSN 2354-1172, email: tapchikhxhnv@gmail.com, tckhxhnv@vnu.edu.vn\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Được thành lập ngày 31\u002F8\u002F2015 (giấy phép hoạt động số 155\u002FGP-BVHTT ngày 11 tháng 5 năm 2015 của Bộ Thông tin và Truyền thông, mã số tiêu chuẩn quốc tế ISSN 2354-1172), Tạp chí Khoa học Xã hội và Nhân văn (Journal of Social Sciences and Humanities) là ấn phẩm khoa học chính thức, duy nhất của Trường Đại học Khoa học Xã hội và Nhân văn, ĐHQG Hà Nội, phát triển và kế thừa Chuyên san Khoa học Xã hội và Nhân văn, Tạp chí Khoa học, ĐHQG Hà Nội.\\nTạp chí xuất bản định kỳ (04 số tiếng Việt\u002Fnăm và 02 số tiếng Anh\u002Fnăm), có nhiệm vụ \"},{\"attributes\":{\"italic\":true},\"insert\":\"công bố, giới thiệu các công trình nghiên cứu khoa học khoa học xã hội và nhân văn của các tác giả là các nhà khoa học trong và ngoài nước, phục vụ giảng dạy, học tập và nghiên cứu khoa học\"},{\"insert\":\". Hội đồng biên tập của Tạp chí hiện bao gồm 33 nhà khoa học có uy tín trong nước và quốc tế. Tạp chí tập trung và ưu tiên đăng tải những bài báo theo định hướng của tinh thần cởi mở, sáng tạo, nhanh chóng vươn lên để tiếp cận và sánh ngang với các tạp chí có uy tín hàng đầu của khu vực và trên thế giới. Nội dung chính của Tạp chí bao gồm các Bài nghiên cứu (khoảng 6000 đến 15000 từ), các bài điểm sách, thông tin khoa học (khoảng 300 đến 1500 từ) được trình bày theo đúng cấu trúc và chuẩn mực của một tạp chí khoa học.\\nCác bài viết của Tạp chí hiện đang được trích dẫn bởi Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services.\\nMọi thông tin xin liên hệ: \"},{\"attributes\":{\"italic\":true},\"insert\":\"Phòng Tạp chí, 701 - E, Trường Đại học Khoa học Xã hội và Nhân văn, 336 Nguyễn Trãi, Thanh Xuân, Hà Nội. ĐT: 024.35581984; email: tckhxhnv@vnu.edu.vn \"},{\"insert\":\"hoặc \"},{\"attributes\":{\"italic\":true},\"insert\":\"tapchikhxhnv@gmail.com \"},{\"insert\":\"\\n\"}]}",{"EN":494,"VI":495},"VNU Journal of Social Sciences and Humanities","Tạp chí Khoa học Xã hội và Nhân văn",[101,102],[],[499],{"id":500,"createTime":501,"updateTime":502,"relativeEntities":503,"slug":504,"properties":505,"entityType":98,"verifyStatus":25,"verifyTime":509,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"url":26,"parentIds":510,"statistic":511},"8b6e349b-0daf-4895-9c3f-85f30f1bfd42","2023-07-31T12:55:58.430+00:00","2026-06-19T02:30:07.899+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Khoa-h%E1%BB%8Dc-X%C3%A3-h%E1%BB%99i-v%C3%A0-Nh%C3%A2n-v%C4%83n-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-H%C3%A0-N%E1%BB%99i",{"title":506},{"EN":507,"VI":508},"VNU University of Social Sciences and Humanities","Trường Đại học Khoa học Xã hội và Nhân văn, Đại học Quốc gia Hà Nội","2023-08-02T15:28:49.057+00:00",[],{"impactFactor":36,"impactFactorByYear":512,"i10Index":59,"i10IndexLast5Year":115,"totalPublication":514,"totalPublicationByYear":515,"totalCitation":518,"totalCitationByYear":519,"totalCitationPerPublication":520,"totalCitationPerPublicationByYear":521,"hindexLast5Year":162,"hindex":162},{"2016":229,"2017":230,"2018":229,"2021":230,"2022":58,"2023":513,"2024":38},0.15,365,{"2013":115,"2014":158,"2015":125,"2016":252,"2017":44,"2018":516,"2019":286,"2020":396,"2021":259,"2022":517,"2023":396,"2024":115,"2025":59,"2026":115},21,42,169,{"2015":283,"2016":135,"2017":52,"2018":50,"2019":298,"2020":53,"2021":359,"2022":115,"2023":115},0.46,{"2015":266,"2016":57,"2017":57,"2018":522,"2019":523,"2020":524,"2021":368,"2022":229,"2023":39},0.38,0.32,0.37,[],"http:\u002F\u002Fjournal.ussh.vnu.edu.vn\u002Findex.php\u002Fvjossh","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F2b8d7b12-2d20-4777-be98-077f44f03c69\u002F0bd0751202944a4b4165b482e6e623e4.png",{"impactFactor":36,"impactFactorByYear":529,"i10Index":162,"i10IndexLast5Year":115,"totalPublication":530,"totalPublicationByYear":531,"totalCitation":537,"totalCitationByYear":538,"totalCitationPerPublication":343,"totalCitationPerPublicationByYear":540,"hindexLast5Year":135,"hindex":135},{"2016":341,"2017":39,"2018":229,"2019":38,"2020":110,"2021":231,"2022":231,"2023":341,"2024":39},764,{"2015":255,"2016":245,"2017":532,"2018":259,"2019":533,"2020":534,"2021":535,"2022":536,"2023":534,"2024":254,"2025":50},111,106,68,92,89,265,{"2015":539,"2016":241,"2017":168,"2018":51,"2019":349,"2020":260,"2021":244,"2022":298,"2023":114},46,{"2015":541,"2016":523,"2017":524,"2018":290,"2019":542,"2020":522,"2021":523,"2022":57,"2023":39},1.48,0.63,{"id":544,"createTime":545,"updateTime":546,"relativeEntities":547,"slug":548,"properties":549,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":558,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":50,"subjectFields":559,"manageAffiliations":560,"indexDatabases":561,"url":562,"thumbnailPath":563,"statistic":564,"gsStatistic":26,"type":26,"analyzePriority":26},"6ec01bd0-15c0-469a-86ac-41339076ae0a","2023-08-10T07:08:33.153+00:00","2026-01-31T21:19:06.362+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Da-li%E1%BB%85u-h%E1%BB%8Dc-Vi%E1%BB%87t-Nam",{"country":550,"issn":551,"introduce":553,"title":555},{"VOID":15},{"VOID":552},"18594824",{"VI":554},"{\"ops\":[{\"insert\":\"Tạp chí “Da liễu học Việt Nam” (Tiếng Anh: Vietnamese Journal of Dermatology and Venereology) thuộc Hội Da liễu Việt Nam, xuất bản 4 số mỗi năm bằng tiếng Việt hoặc tiếng Anh.\\nTạp chí Da liễu học Việt Nam hoạt động với mục đích, tôn chỉ là phổ biến, trao đổi thông tin trong lĩnh vực chuyên ngành da liễu; đăng tải các công trình nghiên cứu khoa học; chuyển giao công nghệ - kinh tế và khoa học kỹ thuật liên quan đến lĩnh vực da liễu.\\nPhạm vi của tạp chí là tất cả các bài báo khoa học, bài tổng quan, giới thiệu ca lâm sàng, … có liên quan tới chuyên ngành da liễu trong và ngoài nước. Tạp chí công bố các công trình nghiên cứu liên quan đến mô hình bệnh tật, các phương pháp chẩn đoán, điều trị, dự phòng và phục hồi chức năng các bệnh thuộc chuyên ngành da liễu. Ngoài ra, tạp chí còn đăng tải các bài tổng quan, cập nhật thông tin, kiến thức, hướng dẫn chẩn đoán, điều trị trong chuyên ngành da liễu trong nước và quốc tế; đăng tải các bài ca lâm sàng đặc biệt trong chuyên ngành da liễu.\\nTạp chí Da liễu học Việt Nam được biết tới là một tạp chí chuyên ngành có uy tín trong lĩnh vực da liễu. Các bài báo về nghiên cứu khoa học đăng trong Tạp chí được bình duyệt một cách nghiêm ngặt bởi ít nhất 2 chuyên gia. Hội đồng biên tập tạp chí bao gồm các nhà khoa học có uy tín (Giáo sư, Phó Giáo sư, Tiến sĩ, Bác sĩ…) trong chuyên ngành da liễu nhằm đảm bảo chất lượng và tính khách quan, khoa học cho các bài viết đăng trên Tạp chí.\\n\"}]}",{"EN":556,"VI":557},"Vietnamese Journal of Dermatology and Venereology","Tạp chí Da liễu học Việt Nam","Admin Import",[],[],[],"https:\u002F\u002Fvjdv.vn\u002Findex.php\u002Fvjdv","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F6ec01bd0-15c0-469a-86ac-41339076ae0a\u002F3cbc81720e58429dc7b1c4d7ab1935ca.jpg",{"impactFactor":36,"impactFactorByYear":565,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":566,"totalPublicationByYear":567,"totalCitation":116,"totalCitationByYear":570,"totalCitationPerPublication":109,"totalCitationPerPublicationByYear":571,"hindexLast5Year":115,"hindex":115},{"2023":38,"2024":230},182,{"2022":568,"2023":45,"2024":569},69,56,{"2022":52,"2023":115},{"2022":40,"2023":229},{"id":573,"createTime":574,"updateTime":575,"relativeEntities":576,"slug":577,"properties":578,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":587,"translateLanguages":26,"viewCount":283,"subjectFields":588,"manageAffiliations":589,"indexDatabases":647,"url":648,"thumbnailPath":649,"statistic":650,"gsStatistic":26,"type":26,"analyzePriority":26},"19221551-7519-47ff-a892-331d1139c64b","2023-09-12T07:03:05.744+00:00","2026-01-24T20:54:40.144+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-S%E1%BB%A9c-kho%E1%BA%BB-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":579,"issn":580,"introduce":582,"title":584},{"VOID":15},{"VOID":581},"27349446",{"EN":583},"{\"ops\":[{\"attributes\":{\"bold\":true},\"insert\":\"1. History\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Science and Technology Development Journal\"},{\"insert\":\" (STDJ) (ISSN 2734-9446), Vietnam National University - Ho Chi Minh City (VNU-HCM) was established in 1997. And the first issue was published in January 1998 with ISSN 1859-0128. Since then, STDJ has become the most important scientific forum of scientists from VNU-HCM as well as other universities. The magazine has undergone 20 years of development and has become a bridge for scientific exchanges, as well as enriching reference materials for the faculty, doctoral students, students of VNU-HCM in particular and other universities, institutes...\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Science and Technology Development Journal - Health Sciences (STDJ-HS) is a subjournal of Science and Technology Development Journal since 2020.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\" \"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"2. Focus and Scope\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Publishing articles with contents on healthcare, research projects in the field of health, advanced directions in health education and management. Therefore, STDJ-HS will accept articles from doctors, administrators, teachers, researchers, graduate students and fellows. The authors will be responsible for the accuracy of the data, opinions, opinions and material cited in the article.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Facilitating the exchange of scientific and technological information and act as a bridge between theory and practice in the community of educators, scientists, managers, policy makers and enterprises in and out of the country.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":585,"VI":586},"VNUHCM JOURNAL OF HEALTH SCIENCES","Tạp chí Khoa học Sức khoẻ Đại học Quốc gia Thành phố Hồ Chí Minh",[101,102],[],[590],{"id":591,"createTime":592,"updateTime":593,"relativeEntities":594,"slug":595,"properties":596,"entityType":98,"verifyStatus":25,"verifyTime":606,"verifyNote":26,"syncStatus":28,"languages":607,"translateLanguages":26,"viewCount":608,"url":609,"parentIds":610,"statistic":611},"fc4c2560-868c-4677-acb1-8686bef88727","2023-06-26T04:48:23.774+00:00","2026-06-19T01:46:17.248+00:00",[],"%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":597,"title":598,"abbreviation":601,"address":603},{"VOID":15},{"EN":599,"VI":600},"Vietnam National University Ho Chi Minh City","Đại học Quốc gia Thành phố Hồ Chí Minh",{"VOID":602},"VNUHCM",{"VI":604,"EN":605},"khu phố 6, Phường Linh Trung, Thành phố Thủ Đức, Thành phố Hồ Chí Minh, Việt Nam","Quarter 6, Linh Trung Ward, Thu Duc City, Ho Chi Minh City, Vietnam","2023-08-16T14:13:07.134+00:00",[101,102],45,"https:\u002F\u002Fvnuhcm.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":612,"i10Index":285,"i10IndexLast5Year":51,"totalPublication":613,"totalPublicationByYear":614,"totalCitation":624,"totalCitationByYear":625,"totalCitationPerPublication":634,"totalCitationPerPublicationByYear":635,"hindexLast5Year":124,"hindex":124},{"2014":36,"2015":38,"2016":109,"2017":39,"2018":229,"2019":38,"2020":110,"2021":171,"2022":110,"2023":110,"2024":171,"2025":229},3708,{"2005":115,"2006":115,"2007":115,"2008":135,"2009":111,"2010":53,"2011":52,"2012":568,"2013":615,"2014":351,"2015":616,"2016":469,"2017":617,"2018":127,"2019":618,"2020":619,"2021":620,"2022":621,"2023":622,"2024":623,"2025":159,"2026":50},164,266,177,226,603,931,314,246,74,2399,{"2006":115,"2008":50,"2010":162,"2011":242,"2012":222,"2013":43,"2014":626,"2015":627,"2016":628,"2017":629,"2018":258,"2019":630,"2020":631,"2021":632,"2022":633,"2023":353,"2024":115},250,124,157,162,152,385,559,128,0.65,{"2006":115,"2008":636,"2010":637,"2011":638,"2012":639,"2013":522,"2014":640,"2015":641,"2016":642,"2017":643,"2018":644,"2019":642,"2020":645,"2021":292,"2022":646,"2023":522,"2024":38},1.33,0.45,2.22,0.39,1.35,0.47,0.67,0.92,0.73,0.64,0.41,[],"http:\u002F\u002Fstdjhs.scienceandtechnology.com.vn\u002Findex.php\u002Fstdjhs","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F19221551-7519-47ff-a892-331d1139c64b\u002F2e10768b7d1e380c36a25ed0c714dd7e.png",{"impactFactor":36,"impactFactorByYear":651,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":652,"totalPublicationByYear":653,"totalCitation":516,"totalCitationByYear":654,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":655,"hindexLast5Year":59,"hindex":59},{"2022":57,"2023":108,"2024":39},79,{"2020":116,"2021":240,"2022":239,"2023":52,"2024":162,"2025":162},{"2020":59,"2021":51,"2022":59},{"2020":443,"2021":387,"2022":54},{"code":657,"data":658,"meta":26},"SUCCESS",{"id":659,"createTime":660,"updateTime":660,"relativeEntities":661,"slug":662,"properties":663,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":668,"manageAffiliations":669,"indexDatabases":670,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},"83289c5a-0e1a-4089-90d0-8447ef02c8ba","2023-12-05T06:03:54.978+00:00",[],"EMC-Ginecolog%C3%ADa-Obstetricia",{"issn":664,"title":666},{"VOID":665},"1283081X",{"EN":667},"EMC - Ginecología-Obstetricia",[],[],[],{"meta":672,"data":674},{"total":673},"233",[675,773,879,938,1042,1157,1202,1279,1323,1383],{"id":676,"createTime":677,"updateTime":678,"relativeEntities":679,"slug":680,"properties":681,"entityType":688,"verifyStatus":25,"verifyTime":689,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":691,"fullTextUrl":26,"authors":692,"publicationType":747,"publisherRelationship":748,"citationCount":36,"citationInfo":762,"publishDate":764,"publishYear":765,"citationAnalyzeStatus":766,"lastCitationAnalyze":767,"indexDatabases":26,"openAccess":26,"references":768,"isForceReanalyzing":772},"2e0022d8-691d-47c1-805b-2646aae83a4e","2024-01-24T08:55:54.986+00:00","2026-06-10T12:40:31.574+00:00",[],"Tratamiento-de-la-f%C3%ADstula-rectovaginal-y-de-las-secuelas-obst%C3%A9tricas",{"title":682,"doi":684,"gsPaper":686},{"ES":683},"Tratamiento de la fístula rectovaginal y de las secuelas obstétricas",{"VOID":685},"10.1016\u002Fs1283-081x(20)43720-8",{"VOID":687},"[\"8941905162942479020\"]","PUBLICATION","2024-05-03T00:37:56.136+00:00","Auto Verify","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X20437208",[693,709,721,733],{"id":694,"sortIndex":59,"researcher":26,"roles":695,"affiliations":697,"properties":706},"39888c05-cf30-4eaf-ab45-faf3ce88e0b8",[696],"AUTHOR",[698],{"id":26,"sortIndex":36,"affiliation":699,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":702,"slug":26,"properties":703,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"d4d18b5e-933d-4c7a-8252-f956d23d19a2","2024-01-24T08:55:55.012+00:00",[],{"title":704},{"VI":705},"Service de chirurgie gynécologique, Hôpital Jeanne-de-Flandre, CHU de Lille, avenue Eugène-Avinée, 59037 Lille cedex, France",{"title":707},{"VI":708},"S. Delplanque",{"id":710,"sortIndex":114,"researcher":26,"roles":711,"affiliations":712,"properties":718},"a42857fa-931d-4443-b6a7-eeb4d3d287d4",[696],[713],{"id":26,"sortIndex":36,"affiliation":714,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":715,"slug":26,"properties":716,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":717},{"VI":705},{"title":719},{"VI":720},"E. Declas",{"id":722,"sortIndex":115,"researcher":26,"roles":723,"affiliations":724,"properties":730},"cf770415-864d-4750-a611-abe739471221",[696],[725],{"id":26,"sortIndex":36,"affiliation":726,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":727,"slug":26,"properties":728,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":729},{"VI":705},{"title":731},{"VI":732},"G. Giraudet",{"id":734,"sortIndex":36,"researcher":26,"roles":735,"affiliations":736,"properties":742},"08fc2047-379d-421d-a1db-869f3b3936fd",[696],[737],{"id":26,"sortIndex":36,"affiliation":738,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":739,"slug":26,"properties":740,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":741},{"VI":705},{"title":743,"gsAuthor":745},{"VI":744},"M. Cosson",{"VOID":746},"[\"mra9H5MAAAAJ\"]","ARTICLE",{"url":691,"publisher":749,"properties":757},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":750,"slug":662,"properties":751,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":754,"manageAffiliations":755,"indexDatabases":756,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":752,"title":753},{"VOID":665},{"EN":667},[],[],[],{"volume":758,"pages":760},{"VOID":759},"56",{"VOID":761},"1-12",{"total":36,"publishYear":36,"statisticByYear":763},{},"2020-05-01",2020,"ERROR_IN_ANALYZE_CITATION","2026-06-10T12:40:31.573+00:00",[769],{"id":26,"text":770,"url":26,"identifiers":771},"Cosson, 2011",{},false,{"id":774,"createTime":775,"updateTime":776,"relativeEntities":777,"slug":778,"properties":779,"entityType":688,"verifyStatus":25,"verifyTime":776,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":786,"fullTextUrl":26,"authors":787,"publicationType":747,"publisherRelationship":863,"citationCount":26,"citationInfo":26,"publishDate":877,"publishYear":878,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"02a8e3ee-d8d6-41d8-86f5-5144853a9b0a","2024-01-11T06:50:21.574+00:00","2024-12-12T00:55:43.470+00:00",[],"Estrategia-de-diagn%C3%B3stico-prenatal-y-tratamiento-de-las-enfermedades-relacionadas-con-los-embarazos-m%C3%BAltiples",{"references":780,"title":782,"doi":784},{"VOID":781},"Evans, 2010, Screening and testing in multiples, Clin Lab Med, 30, 643, 10.1016\u002Fj.cll.2010.05.005\nVayssiere, 2010, Twin pregnancies: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF), Eur J Obstet Gynecol Reprod Biol, 156, 12, 10.1016\u002Fj.ejogrb.2010.12.045\nCuckle, 1998, Down's syndrome screening in twins, J Med Screen, 5, 3, 10.1136\u002Fjms.5.1.3\nSebire, 1997, The prevalence and consequences of missed abortion in twin pregnancies at 10 to 14 weeks of gestation, Br J Obstet Gynaecol, 104, 847, 10.1111\u002Fj.1471-0528.1997.tb12033.x\nSebire, 1996, Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation, Br J Obstet Gynaecol, 103, 999, 10.1111\u002Fj.1471-0528.1996.tb09550.x\nOdibo, 2003, Screening for aneuploidy in twins and higher-order multiples: is first-trimester nuchal translucency the solution?, Obstet Gynecol Surv, 58, 609, 10.1097\u002F01.OGX.0000082369.30519.A8\nGlinianaia, 2008, Congenital anomalies in twins: a register-based study, Hum Reprod, 23, 1306, 10.1093\u002Fhumrep\u002Fden104\nBryan, 1987, Congenital anomalies in twins, Baillieres Clin Obstet Gynaecol, 1, 697, 10.1016\u002FS0950-3552(87)80012-3\nLewi, 2008, The outcome of monochorionic diamniotic twin gestations in the era of invasive fetal therapy: a prospective cohort study, Am J Obstet Gynecol, 199, 514, 10.1016\u002Fj.ajog.2008.03.050\nSepulveda, 2005, Discordant lower urinary tract obstruction in early twin gestations: management and outcome, Obstet Gynecol, 106, 797, 10.1097\u002F01.AOG.0000175833.65983.ee\nWeber, 2010, Genetics and developmental pathology of twinning, Semin Fetal Neonatal Med, 15, 313, 10.1016\u002Fj.siny.2010.06.002\nWeisz, 2004, Tailored management of twin reversed arterial perfusion (trap) sequence, Ultrasound Obstet Gynecol, 23, 451, 10.1002\u002Fuog.1040\nNakata, 2008, Fetoscopic laser photocoagulation of placental communicating vessels for twin-reversed arterial perfusion sequence, J Obstet Gynaecol Res, 34, 649, 10.1111\u002Fj.1447-0756.2008.00901.x\nDiehl, 2007, Selective cord coagulation in acardiac twins, Semin Fetal Neonatal Med, 12, 458, 10.1016\u002Fj.siny.2007.06.008\nRossi, 2008, Laser therapy and serial amnioreduction as treatment for twin-twin transfusion syndrome: a meta-analysis and review of literature, Am J Obstet Gynecol, 198, 147, 10.1016\u002Fj.ajog.2007.09.043\nRoman, 2010, Selective reduction in complicated monochorionic pregnancies: radiofrequency ablation vs. bipolar cord coagulation, Ultrasound Obstet Gynecol, 36, 37, 10.1002\u002Fuog.7567\nDelabaere, 2013, Suivi pédiatrique de 30 grossesses gémellaires monochoriales consécutives traitées par foeticide sélectif, Gynecol Obstet Fertil, 41, 85, 10.1016\u002Fj.gyobfe.2012.12.007\nYamamoto, 2005, Incidence and impact of perioperative complications in 175 fetoscopy-guided laser coagulations of chorionic plate anastomoses in fetofetal transfusion syndrome before 26 weeks of gestation, Am J Obstet Gynecol, 193, 1110, 10.1016\u002Fj.ajog.2005.07.003\nQuintero, 1999, Staging of twin-twin transfusion syndrome, J Perinatol, 19, 550, 10.1038\u002Fsj.jp.7200292\nQuintero, 2003, Stage-based treatment of twin-twin transfusion syndrome, Am J Obstet Gynecol, 188, 1333, 10.1067\u002Fmob.2003.292\nHuber, 2006, Stage-related outcome in twin-twin transfusion syndrome treated by fetoscopic laser coagulation, Obstet Gynecol, 108, 333, 10.1097\u002F01.AOG.0000225945.17022.6b\nHarkness, 2005, Twin-twin transfusion syndrome: where do we go from here?, Semin Perinatol, 29, 296, 10.1053\u002Fj.semperi.2005.10.001\nRoberts, 2008, Interventions for twin-twin transfusion syndrome: a Cochrane review, Ultrasound Obstet Gynecol, 31, 701, 10.1002\u002Fuog.5328\nDelabaere, 2011, Résultats favorables d’une équipe émergente dans le traitement du syndrome transfuseur–transfusé par photocoagulation-laser, Gynecol Obstet Fertil, 39, 482, 10.1016\u002Fj.gyobfe.2011.02.016\nSlaghekke, 2010, Twin anemia-polycythemia sequence: diagnostic criteria, classification, perinatal management and outcome, Fetal Diagn Ther, 27, 181, 10.1159\u002F000304512\nLopriore, 2008, Fetal and neonatal haematological complications in monochorionic twins, Semin Fetal Neonatal Med, 13, 231, 10.1016\u002Fj.siny.2008.02.002\nLopriore, 2009, Residual anastomoses in twin-to-twin transfusion syndrome treated with selective fetoscopic laser surgery: localization, size, and consequences, Am J Obstet Gynecol, 201, 66, 10.1016\u002Fj.ajog.2009.01.010\nRobyr, 2006, Prevalence and management of late fetal complications following successful selective laser coagulation of chorionic plate anastomoses in twin-to-twin transfusion syndrome, Am J Obstet Gynecol, 194, 796, 10.1016\u002Fj.ajog.2005.08.069\nLewi, 2006, Pregnancy and infant outcome of 80 consecutive cord coagulations in complicated monochorionic multiple pregnancies, Am J Obstet Gynecol, 194, 782, 10.1016\u002Fj.ajog.2005.09.013\nHabli, 2009, Incidence of complications in twin-twin transfusion syndrome after selective fetoscopic laser photocoagulation: a single-center experience, Am J Obstet Gynecol, 201, 417, 10.1016\u002Fj.ajog.2009.07.046\nRussell, 2007, Intrauterine growth restriction in monochorionic twins, Semin Fetal Neonatal Med, 12, 439, 10.1016\u002Fj.siny.2007.06.004\nChang, 2009, Clinical outcome and placental territory ratio of monochorionic twin pregnancies and selective intrauterine growth restriction with different types of umbilical artery Doppler, Prenat Diagn, 29, 253, 10.1002\u002Fpd.2193\nDenbow, 2000, Placental angioarchitecture in monochorionic twin pregnancies: relationship to fetal growth, fetofetal transfusion syndrome, and pregnancy outcome, Am J Obstet Gynecol, 182, 417, 10.1016\u002FS0002-9378(00)70233-X\nLeduc, 2005, Persistance of adverse obstetric and neonatal outcomes in monochorionic twins after exclusion of disorders unique to monochorionic placentation, Am J Obstet Gynecol, 193, 1670, 10.1016\u002Fj.ajog.2005.04.007\nAcosta-Rojas, 2007, Twin chorionicity and the risk of adverse perinatal outcome, Int J Gynaecol Obstet, 96, 98, 10.1016\u002Fj.ijgo.2006.11.002\nGratacos, 2004, Prevalence of neurological damage in monochorionic twins with selective intrauterine growth restriction and intermittent absent or reversed end-diastolic umbilical artery flow, Ultrasound Obstet Gynecol, 24, 159, 10.1002\u002Fuog.1105\nIshii, 2009, Perinatal outcome of monochorionic twins with selective intrauterine growth restriction and different types of umbilical artery Doppler under expectant management, Fetal Diagn Ther, 26, 157, 10.1159\u002F000253880\nValsky, 2010, Selective intrauterine growth restriction in monochorionic twins: pathophysiology, diagnostic approach and management dilemmas, Semin Fetal Neonatal Med, 15, 342, 10.1016\u002Fj.siny.2010.07.002\nGratacos, 2007, A classification system for selective intrauterine growth restriction in monochorionic pregnancies according to umbilical artery Doppler flow in the smaller twin, Ultrasound Obstet Gynecol, 30, 28, 10.1002\u002Fuog.4046\nAxt, 1999, Maternal and neonatal outcome of twin pregnancies complicated by single fetal death, J Perinat Med, 27, 221, 10.1515\u002FJPM.1999.031\nLee, 2008, Twin chorionicity and the risk of stillbirth, Obstet Gynecol, 111, 301, 10.1097\u002FAOG.0b013e318160d65d\nOng, 2006, Prognosis for the co-twin following single-twin death: a systematic review, Bjog, 113, 992, 10.1111\u002Fj.1471-0528.2006.01027.x\nWoo, 2000, Single foetal death in twin pregnancies: review of the maternal and neonatal outcomes and management, Hong Kong Med J, 6, 293\nvan Heteren, 1998, Risk for surviving twin after fetal death of co-twin in twin-twin transfusion syndrome, Obstet Gynecol, 92, 215, 10.1016\u002FS0029-7844(98)00159-8\nBejar, 1990, Antenatal origin of neurologic damage in newborn infants. II. Multiple gestations, Am J Obstet Gynecol, 162, 1230, 10.1016\u002F0002-9378(90)90024-2\nNicolini, 1999, Single intrauterine death in monochorionic twin pregnancies, Ultrasound Obstet Gynecol, 14, 297, 10.1046\u002Fj.1469-0705.1999.14050297.x\nSchinzel, 1979, Monozygotic twinning and structural defects, J Pediatr, 95, 921, 10.1016\u002FS0022-3476(79)80278-4\nMoore, 1969, Intrauterine disseminated intravascular coagulation: a syndrome of multiple pregnancy with a dead twin fetus, J Pediatr, 74, 523, 10.1016\u002FS0022-3476(69)80034-X\nWeisz, 2005, Invasive diagnostic procedures in twin pregnancies, Prenat Diagn, 25, 751, 10.1002\u002Fpd.1263\nNieuwint, 1999, “Identical” twins with discordant karyotypes, Prenat Diagn, 19, 72, 10.1002\u002F(SICI)1097-0223(199901)19:1\u003C72::AID-PD465>3.0.CO;2-V\nToth-Pal, 2004, Genetic amniocentesis in multiple pregnancy, Fetal Diagn Ther, 19, 138, 10.1159\u002F000075138\nMujezinovic, 2007, Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review, Obstet Gynecol, 110, 687, 10.1097\u002F01.AOG.0000278820.54029.e3\nDommergues, 1991, Embryo reduction in multifetal pregnancies after infertility therapy: obstetrical risks and perinatal benefits are related to operative strategy, Fertil Steril, 55, 805, 10.1016\u002FS0015-0282(16)54252-6\nEvans, 1994, Transabdominal versus transcervical and transvaginal multifetal pregnancy reduction: international collaborative experience of more than one thousand cases, Am J Obstet Gynecol, 170, 902, 10.1016\u002FS0002-9378(94)70306-X\nWapner, 1990, Selective reduction of multifetal pregnancies, Lancet, 335, 90, 10.1016\u002F0140-6736(90)90550-O\nSentilhes, 2008, Multifetal pregnancy reduction: indications, technical aspects and psychological impact, Presse Med, 37, 295, 10.1016\u002Fj.lpm.2007.05.016\nSenat, 2002, Funipuncture for fetocide in late termination of pregnancy, Prenat Diagn, 22, 354, 10.1002\u002Fpd.290\nBhide, 2002, Comparison of feticide carried out by cordocentesis versus cardiac puncture, Ultrasound Obstet Gynecol, 20, 230, 10.1046\u002Fj.1469-0705.2002.00797.x\nSenat, 2003, The use of lidocaine for fetocide in late termination of pregnancy, Bjog, 110, 296, 10.1046\u002Fj.1471-0528.2003.02217.x\nNielsen, 1991, Analgesic efficacy of low doses of intravenously administered lidocaine on experimental laser-induced pain: a placebo controlled study, Reg Anesth, 16, 28\nRossi, 2009, Umbilical cord occlusion for selective feticide in complicated monochorionic twins: a systematic review of literature, Am J Obstet Gynecol, 200, 123, 10.1016\u002Fj.ajog.2008.08.039\nDelabaere, 2013, Suivi pédiatrique de 30 grossesses gémellaires monochoriales consécutives traitées par fœticide sélectif, Gynecol Obstet Fertil, 41, 85, 10.1016\u002Fj.gyobfe.2012.12.007",{"ES":783},"Estrategia de diagnóstico prenatal y tratamiento de las enfermedades relacionadas con los embarazos múltiples",{"VOID":785},"10.1016\u002Fs1283-081x(13)65365-5","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X13653655",[788,803,815,827,839,851],{"id":789,"sortIndex":36,"researcher":26,"roles":790,"affiliations":791,"properties":800},"a6572e51-5aa5-4115-a749-b8be236a9f71",[696],[792],{"id":26,"sortIndex":36,"affiliation":793,"properties":26},{"id":794,"createTime":795,"updateTime":795,"relativeEntities":796,"slug":26,"properties":797,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"3677a859-5b95-42dd-85d4-27d0c50a01c8","2024-01-11T06:50:21.681+00:00",[],{"title":798},{"VI":799},"Pôle gynéco-obstétrique-reproduction humaine, Centre hospitalier universitaire de Clermont-Ferrand, Centre hospitalier universitaire Estaing, 1, place Lucie-Aubrac, 63003 Clermont-Ferrand cedex 1, France",{"title":801},{"VI":802},"A. Delabaere",{"id":804,"sortIndex":111,"researcher":26,"roles":805,"affiliations":806,"properties":812},"96b7792f-c31e-4cf1-a02e-3f39936930c8",[696],[807],{"id":26,"sortIndex":36,"affiliation":808,"properties":26},{"id":794,"createTime":795,"updateTime":795,"relativeEntities":809,"slug":26,"properties":810,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":811},{"VI":799},{"title":813},{"VI":814},"D. Lémery",{"id":816,"sortIndex":114,"researcher":26,"roles":817,"affiliations":818,"properties":824},"caa7839d-08a4-44d3-8caf-161f5aa1e31b",[696],[819],{"id":26,"sortIndex":36,"affiliation":820,"properties":26},{"id":794,"createTime":795,"updateTime":795,"relativeEntities":821,"slug":26,"properties":822,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":823},{"VI":799},{"title":825},{"VI":826},"F. Desvignes",{"id":828,"sortIndex":59,"researcher":26,"roles":829,"affiliations":830,"properties":836},"ded6f25d-5999-4755-a55e-a0f662dd5de9",[696],[831],{"id":26,"sortIndex":36,"affiliation":832,"properties":26},{"id":794,"createTime":795,"updateTime":795,"relativeEntities":833,"slug":26,"properties":834,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":835},{"VI":799},{"title":837},{"VI":838},"H. Laurichesse-Delmas",{"id":840,"sortIndex":115,"researcher":26,"roles":841,"affiliations":842,"properties":848},"4755ec38-4344-4dc0-a5a3-5afcef6f72f5",[696],[843],{"id":26,"sortIndex":36,"affiliation":844,"properties":26},{"id":794,"createTime":795,"updateTime":795,"relativeEntities":845,"slug":26,"properties":846,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":847},{"VI":799},{"title":849},{"VI":850},"S. Curinier",{"id":852,"sortIndex":162,"researcher":26,"roles":853,"affiliations":854,"properties":860},"444c2686-0290-4423-852c-e0810bccc815",[696],[855],{"id":26,"sortIndex":36,"affiliation":856,"properties":26},{"id":794,"createTime":795,"updateTime":795,"relativeEntities":857,"slug":26,"properties":858,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":859},{"VI":799},{"title":861},{"VI":862},"D. Gallot",{"url":786,"publisher":864,"properties":872},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":865,"slug":662,"properties":866,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":869,"manageAffiliations":870,"indexDatabases":871,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":867,"title":868},{"VOID":665},{"EN":667},[],[],[],{"volume":873,"pages":875},{"VOID":874},"49",{"VOID":876},"1-11","2013-09-01",2013,{"id":880,"createTime":881,"updateTime":882,"relativeEntities":883,"slug":884,"properties":885,"entityType":688,"verifyStatus":25,"verifyTime":882,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":892,"fullTextUrl":26,"authors":893,"publicationType":747,"publisherRelationship":922,"citationCount":26,"citationInfo":26,"publishDate":936,"publishYear":937,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"422bfb39-c857-4ff6-88d3-0d3aaadfd20d","2023-11-25T16:57:54.297+00:00","2024-12-14T21:21:05.113+00:00",[],"V%C3%B3mitos-incoercibles-durante-el-embarazo",{"references":886,"title":888,"doi":890},{"VOID":887},"Matthews, 2014, Interventions for nausea and vomiting in early pregnancy, Cochrane Database Syst Rev, CD007575\nEliakim, 2000, Hyperemesis gravidarum: a current review, Am J Perinatol, 17, 207, 10.1055\u002Fs-2000-9424\nEinarson, 2013, Quantifying the global rates of nausea and vomiting of pregnancy: a meta analysis, J Popul Ther Clin Pharmacol, 20, e171\nGazmararian, 2002, Hospitalizations during pregnancy among managed care enrollees, Obstet Gynecol, 100, 94\nBailit, 2005, Hyperemesis gravidarium: epidemiologic findings from a large cohort, Am J Obstet Gynecol, 193, 811, 10.1016\u002Fj.ajog.2005.02.132\nPiwko, 2007, The weekly cost of nausea and vomiting of pregnancy for women calling the Toronto Motherisk Program, Curr Med Res Opin, 23, 833, 10.1185\u002F030079907X178739\nNiebyl, 2010, Clinical practice. Nausea and vomiting in pregnancy, N Engl J Med, 363, 1544, 10.1056\u002FNEJMcp1003896\nMiller, 2002, Nausea and vomiting in pregnancy: the problem of perception--is it really a disease?, Am J Obstet Gynecol, 186, S182, 10.1067\u002Fmob.2002.122594\nGoodwin, 1992, Transient hyperthyroidism and hyperemesis gravidarum: clinical aspects, Am J Obstet Gynecol, 167, 648, 10.1016\u002FS0002-9378(11)91565-8\nGadsby, 1997, Pregnancy nausea related to women's obstetric and personal histories, Gynecol Obstet Invest, 43, 108, 10.1159\u002F000291833\nVerberg, 2005, Hyperemesis gravidarum, a literature review, Hum Reprod Update, 11, 527, 10.1093\u002Fhumupd\u002Fdmi021\nGoodwin, 1994, Increased concentration of the free beta-subunit of human chorionic gonadotropin in hyperemesis gravidarum, Acta Obstet Gynecol Scand, 73, 770, 10.3109\u002F00016349409072502\nTan, 2002, Transient hyperthyroidism of hyperemesis gravidarum, BJOG, 109, 683, 10.1111\u002Fj.1471-0528.2002.01223.x\nAl-Yatama, 2002, Hormone profile of Kuwaiti women with hyperemesis gravidarum, Arch Gynecol Obstet, 266, 218, 10.1007\u002Fs004040100210\nDeruelle, 2002, Vomissements incoercibles du premier trimestre de la grossesse : rôle de l’hyperthyroïdie biologique et du sexe fœtal, Gynecol Obstet Fertil, 30, 204, 10.1016\u002FS1297-9589(02)00296-5\nDucarme, 2007, Pathologies thyroïdiennes et grossesse, Rev Med Interne, 28, 314, 10.1016\u002Fj.revmed.2007.01.011\nNegro, 2011, Thyroid disease in pregnancy, Best Pract Res Clin Endocrinol Metab, 25, 927, 10.1016\u002Fj.beem.2011.07.010\nLagiou, 2003, Nausea and vomiting in pregnancy in relation to prolactin, estrogens, and progesterone: a prospective study, Obstet Gynecol, 101, 639\nShirin, 2004, Positive serology for Helicobacter pylori and vomiting in the pregnancy, Arch Gynecol Obstet, 270, 10, 10.1007\u002Fs00404-002-0473-6\nSandven, 2009, Helicobacter pylori infection and hyperemesis gravidarum: a systematic review and meta-analysis of case-control studies, Acta Obstet Gynecol Scand, 88, 1190, 10.3109\u002F00016340903284927\nCohen, 2007, Approche psychosomatique des vomissements incoercibles du premier trimestre, Gynecol Obstet Fertil, 35, 565, 10.1016\u002Fj.gyobfe.2007.04.005\nKarpel, 2004, L’approche psychologique des vomissements incoercibles gravidiques, J Gynecol Obstet Biol Reprod, 33, 623, 10.1016\u002FS0368-2315(04)96603-3\nSimpson, 2001, Psychological factors and hyperemesis gravidarum, J Womens Health Gend Based Med, 10, 471, 10.1089\u002F152460901300233948\nTorgersen, 2008, Nausea and vomiting of pregnancy in women with bulimia nervosa and eating disorders not otherwise specified, Int J Eat Disord, 41, 722, 10.1002\u002Feat.20564\nDayan, 1999\nBuckwalter, 2002, Psychological factors in the etiology and treatment of severe nausea and vomiting in pregnancy, Am J Obstet Gynecol, 186, S210, 10.1067\u002Fmob.2002.122600\nFell, 2006, Risk factors for hyperemesis gravidarum requiring hospital admission during pregnancy, Obstet Gynecol, 107, 277, 10.1097\u002F01.AOG.0000195059.82029.74\nTrogstad, 2005, Recurrence risk in hyperemesis gravidarum, BJOG, 112, 1641, 10.1111\u002Fj.1471-0528.2005.00765.x\nChraïbi, 2015, Hyperemesis gravidarum: étude de cohorte rétrospective française (109 patientes), Presse Med, 44, e13, 10.1016\u002Fj.lpm.2014.04.028\nVikanes, 2010, Recurrence of hyperemesis gravidarum across generations: population based cohort study, Br Med J, 340, c2050\nVilming, 2000, Hyperemesis gravidarum in a contemporary population in Oslo, Acta Obstet Gynecol Scand, 79, 640\nLouik, 2006, Nausea and vomiting in pregnancy: maternal characteristics and risk factors, Paediatr Perinat Epidemiol, 20, 270, 10.1111\u002Fj.1365-3016.2006.00723.x\nEinarson, 2007, Existence and severity of nausea and vomiting in pregnancy (NVP) with different partners, J Obstet Gynaecol, 27, 360, 10.1080\u002F01443610701327362\nRhodes, 1984, Development of reliable and valid measures of nausea and vomiting, Cancer Nurs, 7, 33, 10.1097\u002F00002820-198402000-00003\nZhou, 2001, Rhodes Index of Nausea and Vomiting--Form 2 in pregnant women. A confirmatory factor analysis, Nurs Res, 50, 251, 10.1097\u002F00006199-200107000-00009\nKoren, 2002, Motherisk-PUQE (pregnancy-unique quantification of emesis and nausea) scoring system for nausea and vomiting of pregnancy, Am J Obstet Gynecol, 186, S228, 10.1067\u002Fmob.2002.123054\nLacasse, 2008, Validity of a modified Pregnancy-Unique Quantification of Emesis and Nausea (PUQE) scoring index to assess severity of nausea and vomiting of pregnancy, Am J Obstet Gynecol, 198, 10.1016\u002Fj.ajog.2007.05.051\nEbrahimi, 2009, Nausea and vomiting of pregnancy: using the 24-hour Pregnancy-Unique Quantification of Emesis (PUQE-24) scale, J Obstet Gynaecol Can, 31, 803, 10.1016\u002FS1701-2163(16)34298-0\nMagee, 2002, Development of a health-related quality of life instrument for nausea and vomiting of pregnancy, Am J Obstet Gynecol, 186, S232, 10.1067\u002Fmob.2002.122604\nLacasse, 2008, Validation of the nausea and vomiting of pregnancy specific health related quality of life questionnaire, Health Qual Life Outcomes, 6, 32, 10.1186\u002F1477-7525-6-32\nMunch, 2011, Health-related quality of life in women with nausea and vomiting of pregnancy: the importance of psychosocial context, J Perinatol, 31, 10, 10.1038\u002Fjp.2010.54\nWood, 2013, Nausea and vomiting in pregnancy: blooming or bloomin’ awful? A review of the literature, Women Birth, 26, 100, 10.1016\u002Fj.wombi.2012.10.001\nBroussard, 1998, Nausea and vomiting of pregnancy, Gastroenterol Clin North Am, 27, 123, 10.1016\u002FS0889-8553(05)70350-2\nEboué, 2006, Une complication rare des vomissements gravidiques: l’encéphalopathie de Gayet-Wernicke, J Gynecol Obstet Biol Reprod, 35, 822, 10.1016\u002FS0368-2315(06)76486-9\nDodds, 2006, Outcomes of pregnancies complicated by hyperemesis gravidarum, Obstet Gynecol, 107, 285, 10.1097\u002F01.AOG.0000195060.22832.cd\nVeenendaal, 2011, Consequences of hyperemesis gravidarum for offspring: a systematic review and meta-analysis, BJOG, 118, 1302, 10.1111\u002Fj.1471-0528.2011.03023.x\nHastoy, 2015, L’hyperémèse gravidique : quelles conséquences sur la grossesse ?, J Gynecol Obstet Biol Reprod, 44, 154, 10.1016\u002Fj.jgyn.2013.12.003\nMcCarthy, 2011, A prospective cohort study investigating associations between hyperemesis gravidarum and cognitive, behavioural and emotional well-being in pregnancy, PLoS One, 6, e27678, 10.1371\u002Fjournal.pone.0027678\nBoneva, 1999, Nausea during pregnancy and congenital heart defects: a population-based case-control study, Am J Epidemiol, 149, 717, 10.1093\u002Foxfordjournals.aje.a009880\nBolin, 2013, Hyperemesis gravidarum and risks of placental dysfunction disorders: a population-based cohort study, BJOG, 120, 541, 10.1111\u002F1471-0528.12132\nGoodwin, 1998, Hyperemesis gravidarum, Clin Obstet Gynecol, 41, 597, 10.1097\u002F00003081-199809000-00014\nQuinlan, 2003, Nausea and vomiting of pregnancy, Am Fam Physician, 68, 121\nDavis, 2004, Nausea and vomiting of pregnancy: an evidence-based review, J Perinat Neonatal Nurs, 18, 312, 10.1097\u002F00005237-200410000-00002\nAmerican College of Obstetrics and Gynecology, 2004, ACOG (American College of Obstetrics and Gynecology) Practice Bulletin: nausea and vomiting of pregnancy, Obstet Gynecol, 103, 803, 10.1097\u002F00006250-200404000-00045\nJoshi, 2010, Liver disease in pregnancy, Lancet, 375, 594, 10.1016\u002FS0140-6736(09)61495-1\nThan, 2013, Liver abnormalities in pregnancy, Best Pract Res Clin Gastroenterol, 27, 565, 10.1016\u002Fj.bpg.2013.06.015\nGuettrot-Imbert, 2015, Pathologies hépatiques et grossesse, Rev Med Interne, 36, 211, 10.1016\u002Fj.revmed.2014.10.355\nBacq, 2011, Liver diseases unique to pregnancy: a 2010 update, Clin Res Hepatol Gastroenterol, 35, 182, 10.1016\u002Fj.clinre.2010.11.011\nMufti, 2012, Liver disease in pregnancy, Clin Liver Dis, 16, 247, 10.1016\u002Fj.cld.2012.03.011\nMcCarthy, 2014, Day care compared with inpatient management of nausea and vomiting of pregnancy: a randomized controlled trial, Obstet Gynecol, 124, 743, 10.1097\u002FAOG.0000000000000449\nHaute Autorité de santé. Infos_femmes_enceintes_rap.pdf. Disponible sur: www.has-sante.fr\u002Fportail\u002Fupload\u002Fdocs\u002Fapplication\u002Fpdf\u002Finfos_femmes_enceintes_rap.pdf.\nVutyavanich, 2001, Ginger for nausea and vomiting in pregnancy: randomized, double-masked, placebo-controlled trial, Obstet Gynecol, 97, 577\nOzgoli, 2009, Effects of ginger capsules on pregnancy, nausea, and vomiting, J Altern Complement Med, 15, 243, 10.1089\u002Facm.2008.0406\nViljoen, 2014, A systematic review and meta-analysis of the effect and safety of ginger in the treatment of pregnancy-associated nausea and vomiting, Nutr J, 13, 20, 10.1186\u002F1475-2891-13-20\nKnight, 2001, Effect of acupuncture on nausea of pregnancy: a randomized, controlled trial, Obstet Gynecol, 97, 184\nRoscoe, 2002, Acupressure and acustimulation bands for control of nausea: a brief review, Am J Obstet Gynecol, 186, S244, 10.1067\u002Fmob.2002.122606\nMaltepe, 2013, The management of nausea and vomiting of pregnancy and hyperemesis gravidarum--a 2013 update, J Popul Ther Clin Pharmacol, 20, e184\nClark, 2014, The outpatient management and special considerations of nausea and vomiting in pregnancy, Semin Perinatol, 38, 496, 10.1053\u002Fj.semperi.2014.08.014\nWilliamson, 2001, Drugs in pregnancy. Gastrointestinal disease, Best Pract Res Clin Obstet Gynaecol, 15, 937, 10.1053\u002Fbeog.2001.0239\nNational Collaborating Centre for Women's and Children's Health (UK), 2008\nSahakian, 1991, Vitamin B6 is effective therapy for nausea and vomiting of pregnancy: a randomized, double-blind placebo-controlled study, Obstet Gynecol, 78, 33\nMazzotta, 2000, A risk-benefit assessment of pharmacological and nonpharmacological treatments for nausea and vomiting of pregnancy, Drugs, 59, 781, 10.2165\u002F00003495-200059040-00005\nGill, 2007, The safety of drugs for the treatment of nausea and vomiting of pregnancy, Expert Opin Drug Saf, 6, 685, 10.1517\u002F14740338.6.6.685\nKoren, 2010, Effectiveness of delayed-release doxylamine and pyridoxine for nausea and vomiting of pregnancy: a randomized placebo controlled trial, Am J Obstet Gynecol, 203, 10.1016\u002Fj.ajog.2010.07.030\nSlaughter, 2014, FDA approval of doxylamine-pyridoxine therapy for use in pregnancy, N Engl J Med, 370, 1081, 10.1056\u002FNEJMp1316042\nKoren, 2014, Treating morning sickness in the United States-changes in prescribing are needed, Am J Obstet Gynecol, 211, 602, 10.1016\u002Fj.ajog.2014.08.017\nMohammadbeigi, 2011, Comparing the effects of ginger and metoclopramide on the treatment of pregnancy nausea, Pak J Biol Sci, 14, 817, 10.3923\u002Fpjbs.2011.817.820\nPasternak, 2013, Metoclopramide in pregnancy and risk of major congenital malformations and fetal death, JAMA, 310, 1601, 10.1001\u002Fjama.2013.278343\nAnderka, 2012, Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects, Birth Defects Res A Clin Mol Teratol, 94, 22, 10.1002\u002Fbdra.22865\nNelson-Piercy, 2001, Randomised, double-blind, placebo-controlled trial of corticosteroids for the treatment of hyperemesis gravidarum, BJOG, 108, 9\nPark-Wyllie, 2000, Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies, Teratology, 62, 385, 10.1002\u002F1096-9926(200012)62:6\u003C385::AID-TERA5>3.0.CO;2-Z\nHamaoui, 2003, Nutritional assessment and support during pregnancy, Gastroenterol Clin North Am, 32, 59, 10.1016\u002FS0889-8553(02)00132-2\nVaisman, 2004, Nasojejunal feeding in hyperemesis gravidarum--a preliminary study, Clin Nutr, 23, 53, 10.1016\u002FS0261-5614(03)00088-8\nLub-Moss, 1997, Clinical experience with patients suffering from hyperemesis gravidarum (severe nausea and vomiting during pregnancy): thoughts about subtyping of patients, treatment and counseling models, Patient Educ Couns, 31, 65, 10.1016\u002FS0738-3991(97)01011-2",{"ES":889},"Vómitos incoercibles durante el embarazo",{"VOID":891},"10.1016\u002Fs1283-081x(15)76286-7","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X15762867",[894,910],{"id":895,"sortIndex":115,"researcher":26,"roles":896,"affiliations":897,"properties":907},"410e8b18-529f-46ac-b5d7-d1482afafc9d",[696],[898],{"id":26,"sortIndex":36,"affiliation":899,"properties":26},{"id":900,"createTime":901,"updateTime":901,"relativeEntities":902,"slug":903,"properties":904,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"562d4235-a887-4951-bd59-db0fde7807bf","2023-11-25T16:57:54.310+00:00",[],"Service-de-gyn%C3%A9cologie-obst%C3%A9trique-Centre-hospitalier-d%C3%A9partemental-Vend%C3%A9e-85000-La-Roche-sur-Yon-France",{"title":905},{"VI":906},"Service de gynécologie-obstétrique, Centre hospitalier départemental Vendée, 85000 La Roche-sur-Yon, France",{"title":908},{"VI":909},"V. Dochez",{"id":911,"sortIndex":36,"researcher":26,"roles":912,"affiliations":913,"properties":919},"8939d0dc-009c-42d2-8492-3e4a253491d8",[696],[914],{"id":26,"sortIndex":36,"affiliation":915,"properties":26},{"id":900,"createTime":901,"updateTime":901,"relativeEntities":916,"slug":903,"properties":917,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":918},{"VI":906},{"title":920},{"VI":921},"G. Ducarme",{"url":892,"publisher":923,"properties":931},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":924,"slug":662,"properties":925,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":928,"manageAffiliations":929,"indexDatabases":930,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":926,"title":927},{"VOID":665},{"EN":667},[],[],[],{"volume":932,"pages":934},{"VOID":933},"52",{"VOID":935},"1-8","2016-03-01",2016,{"id":939,"createTime":940,"updateTime":941,"relativeEntities":942,"slug":943,"properties":944,"entityType":688,"verifyStatus":25,"verifyTime":941,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":951,"fullTextUrl":26,"authors":952,"publicationType":747,"publisherRelationship":1027,"citationCount":26,"citationInfo":26,"publishDate":1040,"publishYear":1041,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"002e3cd9-61c1-4be7-8918-39202067b94e","2023-12-29T14:13:24.827+00:00","2024-12-15T10:44:17.649+00:00",[],"Tratamiento-de-las-neoplasias-intraepiteliales-del-cuello-uterino-l%C3%A1ser-crioterapia-conizaci%C3%B3n-resecci%C3%B3n-con-asa-de-diatermia",{"references":945,"title":947,"doi":949},{"VOID":946},"Belot, 2008, Cancer incidence and mortality in France over the period 1980-2005, Rev Epidemiol Sante Publique, 56, 159, 10.1016\u002Fj.respe.2008.03.117\nLeveque, 2008, Prevention of cervical cancer. Method and organization, J Gynecol Obstet Biol Reprod (Paris), 37, S112\nCNGOF, 2007, Recommandations pour la pratique clinique\nRouzier, 2008, Management of CIN1, J Gynecol Obstet Biol Reprod (Paris), 37, S114, 10.1016\u002Fj.jgyn.2007.11.017\nOstor, 1993, Natural history of cervical intraepithelial neoplasia: a critical review, Int J Gynecol Pathol, 12, 186, 10.1097\u002F00004347-199304000-00018\nMartin-Hirsch P, Paraskevaidis E, Bryant A, Dickinson HO, Keep SL. Surgery for cervical intraepithelial neoplasia. Cochrane Database Syst Rev 2010(6):CD001318.\nMartin-Hirsch PL, Paraskevaidis E, Kitchener H. Surgery for cervical intraepithelial neoplasia. Cochrane Database Syst Rev 2000(2):CD001318.\nMergui, 2009, Charte de qualité en colposcopie et pathologie cervico-vaginale\nBaggish, 1980, High-power-density carbon dioxide laser therapy for early cervical neoplasia, Am J Obstet Gynecol, 136, 117, 10.1016\u002F0002-9378(80)90576-1\nBaggish, 1983, Laser management of cervical intraepithelial neoplasia, Clin Obstet Gynecol, 26, 980, 10.1097\u002F00003081-198312000-00021\nJordan, 1979, Laser treatment of cervical intraepithelial neoplasia, Obstet Gynecol Surv, 34, 831, 10.1097\u002F00006254-197911000-00016\nJordan, 1985, The treatment of cervical intraepithelial neoplasia by laser vaporization, Br J Obstet Gynaecol, 92, 394, 10.1111\u002Fj.1471-0528.1985.tb01114.x\nHatch, 1995, Cryotherapy, Baillieres Clin Obstet Gynaecol, 9, 133, 10.1016\u002FS0950-3552(05)80362-1\nTownsend, 1983, Cryotherapy and carbon dioxide laser management of cervical intraepithelial neoplasia: a controlled comparison, Obstet Gynecol, 61, 75\nOstergard, 1968, Treatment of chronic cervicitis by cryotherapy, Am J Obstet Gynecol, 102, 426, 10.1016\u002F0002-9378(68)90015-X\nSankaranarayanan, 2009, HPV screening for cervical cancer in rural India, N Engl J Med, 360, 1385, 10.1056\u002FNEJMoa0808516\nMartel, 2000, Utilization of CO2 lasers in continuous or pulsed mode for conizations: apropos of 230 cases, Gynecol Obstet Fertil, 28, 537\nMathevet, 1994, A randomized prospective study comparing three techniques of conization: cold knife, laser, and LEEP, Gynecol Oncol, 54, 175, 10.1006\u002Fgyno.1994.1189\nMazouni, 2005, Conservative treatment of cervical intraepithelial neoplasia using a cold-knife section technique, Eur J Obstet Gynecol Reprod Biol, 121, 86, 10.1016\u002Fj.ejogrb.2004.11.018\nLuesley, 1985, Complications of cone biopsy related to the dimensions of the cone and the influence of prior colposcopic assessment, Br J Obstet Gynaecol, 92, 158, 10.1111\u002Fj.1471-0528.1985.tb01068.x\nLeiman, 1980, Pregnancy following conization of the cervix: complications related to cone size, Am J Obstet Gynecol, 136, 14, 10.1016\u002F0002-9378(80)90556-6\nPrendiville, 1989, Large loop excision of the transformation zone (LLETZ). A new method of management for women with cervical intraepithelial neoplasia, Br J Obstet Gynaecol, 96, 1054, 10.1111\u002Fj.1471-0528.1989.tb03380.x\nPrendiville, 2005, Recent innovations in colposcopy practice, Best Pract Res, 19, 779, 10.1016\u002Fj.bpobgyn.2005.06.011\nPrendiville, 1993\nHatch, 1981, Cryosurgery of cervical intraepithelial neoplasia, Obstet Gynecol, 57, 692\nPopkin, 1978, Cryosurgery for the treatment of cervical intraepithelial neoplasia, Am J Obstet Gynecol, 130, 551, 10.1016\u002F0002-9378(78)90074-1\nTabor, 1990, Cold-knife and laser conization for cervical intraepithelial neoplasia, Obstet Gynecol, 76, 633\nBostofte, 1986, Conization by carbon dioxide laser or cold knife in the treatment of cervical intra-epithelial neoplasia, Acta Obstet Gynecol Scand, 65, 199, 10.3109\u002F00016348609155170\nParaskevaidis, 2001, Large loop excision of the transformation zone for treating cervical intraepithelial neoplasia: a 12-year experience, Anticancer Res, 21, 3097\nSoutter, 1997, Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia, Lancet, 349, 978, 10.1016\u002FS0140-6736(96)08295-5\nWright, 2007, 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ, J Lower Genital Tract Dis, 11, 223, 10.1097\u002FLGT.0b013e318159408b\nLapaquette, 1993, Management of patients with positive margins after cervical conization, Obstet Gynecol, 82, 440\nReich, 2002, Cervical intraepithelial neoplasia III: long-term follow-up after cold-knife conization with involved margins, Obstet Gynecol, 99, 193, 10.1016\u002FS0029-7844(01)01683-0\nGonzalez, 2001, Recurrence of dysplasia after loop electrosurgical excision procedures with long-term follow-up, Am J Obstet Gynecol, 184, 315, 10.1067\u002Fmob.2001.109937\nGhaem-Maghami, 2007, Incomplete excision of cervical intraepithelial neoplasia and risk of treatment failure: a meta-analysis, Lancet Oncol, 8, 985, 10.1016\u002FS1470-2045(07)70283-8\nParaskevaidis, 2004, The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature, Cancer Treat Rev, 30, 205, 10.1016\u002Fj.ctrv.2003.07.008\nArbyn, 2005, Clinical utility ofHPV-DNAdetection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence, Gynecol Oncol, 99, S7, 10.1016\u002Fj.ygyno.2005.07.033\nMergui, 2008, Guidelines for the follow-up of women treated for high-grade cervical neoplasia, J Gynecol Obstet Biol Reprod (Paris), 37, S121, 10.1016\u002Fj.jgyn.2007.11.022\nRobinson, 1997, Management of cervical intraepithelial neoplasia during pregnancy with LOOP excision, Gynecol Oncol, 64, 153, 10.1006\u002Fgyno.1996.4546\nBaldauf, 1995, Colposcopy and directed biopsy reliability during pregnancy: a cohort study, Eur J Obstet Gynecol Reprod Biol, 62, 31, 10.1016\u002F0301-2115(95)02178-A\nBergeron, 2007, Recommandations pour la pratique clinique; prévention du cancer du col de l’utérus\nSharp, 2009, Aftereffects reported by women following colposcopy, cervical biopsies and LLETZ: results from the TOMBOLA trial, BJOG, 116, 1506, 10.1111\u002Fj.1471-0528.2009.02263.x\nKyrgiou, 2006, Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis, Lancet, 367, 489, 10.1016\u002FS0140-6736(06)68181-6\nArbyn, 2008, Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis, BMJ, 337, a1284, 10.1136\u002Fbmj.a1284\nKennedy, 1993, LLETZ and infertility, Br J Obstet Gynaecol, 100, 965, 10.1111\u002Fj.1471-0528.1993.tb15123.x\nTurlington, 1996, Impact of the loop electrosurgical excision procedure on future fertility, J Reprod Med, 41, 815\nBigrigg, 1994, Efficacy and safety of large-loop excision of the transformation zone, Lancet, 343, 32, 10.1016\u002FS0140-6736(94)90881-8\nArbyn, 2006, Clinical applications of HPV testing: A summary of meta-analyses, Vaccine, 24, S78, 10.1016\u002Fj.vaccine.2006.05.117\nMergui, 2008, What kind of follow-up after surgical treatment for high-grade cervix lesion?, Gynecol Obstet Fertil, 36, 441, 10.1016\u002Fj.gyobfe.2008.02.011\nCarcopino, 2008, Specific timing for colposcopy: is it worthwhile?, Obstet Gynecol, 111, 373, 10.1097\u002FAOG.0b013e31816276a4\nParaskevaidis, 2001, Effects of ball cauterization following loop excision and follow-up colposcopy, Obstet Gynecol, 97, 617, 10.1016\u002FS0029-7844(00)01194-7\nParaskevaidis, 2007, Have we dismissed ablative treatment too soon in colposcopy practice?, BJOG, 114, 3, 10.1111\u002Fj.1471-0528.2006.01178.x\nMitchell, 1998, Colposcopy for the diagnosis of squamous intraepithelial lesions: a meta-analysis, Obstet Gynecol, 91, 626, 10.1016\u002FS0029-7844(98)00006-4\nCastle, 2007, The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS report, Am J Clin Pathol, 127, 805, 10.1309\u002FPT3PNC1QL2F4D2VL\nPretorius, 2007, Inappropriate gold standard bias in cervical cancer screening studies, Int J Cancer, 121, 2218, 10.1002\u002Fijc.22991\nPretorius, 2006, Subsequent risk and presentation of cervical intraepithelial neoplasia (CIN) 3 or cancer after a colposcopic diagnosis of CIN 1 or less, Am J Obstet Gynecol, 195, 1260, 10.1016\u002Fj.ajog.2006.07.036\nWise, 2009, Age for starting cervical cancer screening in England will not be lowered, BMJ, 338, b2583, 10.1136\u002Fbmj.b2583\nArbyn, 2009, Trends of cervical cancer mortality in the member states of the European Union, Eur J Cancer, 45, 2640, 10.1016\u002Fj.ejca.2009.07.018\nMergui JL, Marchetta J, Prendiville W, Gondry J, Carcopino X, Boubli L. Colposcopic risk assessment method and management guide Eurogin. Monaco. 2010.\nMergui, 2009, Faut-il modifier la classification colposcopique ?",{"ES":948},"Tratamiento de las neoplasias intraepiteliales del cuello uterino: láser, crioterapia, conización, resección con asa de diatermia",{"VOID":950},"10.1016\u002Fs1283-081x(12)60837-6","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X12608376",[953,968,980,995,1010],{"id":954,"sortIndex":111,"researcher":26,"roles":955,"affiliations":956,"properties":965},"fa1f46dd-b42b-4d06-9719-a5ae52a0f3d4",[696],[957],{"id":26,"sortIndex":36,"affiliation":958,"properties":26},{"id":959,"createTime":960,"updateTime":960,"relativeEntities":961,"slug":26,"properties":962,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"5df4b04d-7c82-4707-b561-fa501d1f7dee","2023-12-29T14:13:24.843+00:00",[],{"title":963},{"VI":964},"Service de gynécologie obstétrique, Hôpital Nord, Chemin des Bourrely, 13015 Marseille, France",{"title":966},{"VI":967},"L. Boubli",{"id":969,"sortIndex":36,"researcher":26,"roles":970,"affiliations":971,"properties":977},"b037d821-f367-4e66-b11a-c80011d072f7",[696],[972],{"id":26,"sortIndex":36,"affiliation":973,"properties":26},{"id":959,"createTime":960,"updateTime":960,"relativeEntities":974,"slug":26,"properties":975,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":976},{"VI":964},{"title":978},{"VI":979},"X. Carcopino",{"id":981,"sortIndex":59,"researcher":26,"roles":982,"affiliations":983,"properties":992},"a5084f39-5967-429e-827d-92d3344eb8ef",[696],[984],{"id":26,"sortIndex":36,"affiliation":985,"properties":26},{"id":986,"createTime":987,"updateTime":987,"relativeEntities":988,"slug":26,"properties":989,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"936d5149-1107-4355-9a91-f1f3138ddf5a","2023-12-29T14:13:24.888+00:00",[],{"title":990},{"VI":991},"Service d’anatomie pathologique, Hôpital Nord, Chemin des Bourrely, 13015 Marseille, France",{"title":993},{"VI":994},"C. Taranger-Charpin",{"id":996,"sortIndex":114,"researcher":26,"roles":997,"affiliations":998,"properties":1007},"9af593b3-1c82-42ac-9ed4-b07f07709bf5",[696],[999],{"id":26,"sortIndex":36,"affiliation":1000,"properties":26},{"id":1001,"createTime":1002,"updateTime":1002,"relativeEntities":1003,"slug":26,"properties":1004,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"6c4d805b-4df3-4d29-9789-69197553bfea","2023-12-29T14:13:24.872+00:00",[],{"title":1005},{"VI":1006},"Department of Obstetrics and Gynaecology, Royal College of Surgeons in Ireland, The Coombe Women's Hospital, Dublin 8, Irlande",{"title":1008},{"VI":1009},"W. Prendiville",{"id":1011,"sortIndex":115,"researcher":26,"roles":1012,"affiliations":1013,"properties":1024},"29addb7f-e6ec-4b81-b126-7dd9f2758d85",[696],[1014],{"id":26,"sortIndex":36,"affiliation":1015,"properties":26},{"id":1016,"createTime":1017,"updateTime":1018,"relativeEntities":1019,"slug":1020,"properties":1021,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"069eb286-5d60-4761-8e60-d9e4bc824644","2024-01-04T03:15:24.721+00:00","2025-06-11T19:41:01.601+00:00",[],"Service-de-gyn%C3%A9cologie-obst%C3%A9trique-et-m%C3%A9decine-de-la-reproduction-h%C3%B4pital-Tenon-4-rue-de-la-Chine-75020-Paris-France",{"title":1022},{"VI":1023},"Service de gynécologie-obstétrique et médecine de la reproduction, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France",{"title":1025},{"VI":1026},"J.-L. Mergui",{"url":951,"publisher":1028,"properties":1036},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1029,"slug":662,"properties":1030,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1033,"manageAffiliations":1034,"indexDatabases":1035,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1031,"title":1032},{"VOID":665},{"EN":667},[],[],[],{"volume":1037,"pages":1039},{"VOID":1038},"48",{"VOID":761},"2012-01-01",2012,{"id":1043,"createTime":1044,"updateTime":1045,"relativeEntities":1046,"slug":1047,"properties":1048,"entityType":688,"verifyStatus":25,"verifyTime":1045,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1055,"fullTextUrl":26,"authors":1056,"publicationType":747,"publisherRelationship":1143,"citationCount":26,"citationInfo":26,"publishDate":1156,"publishYear":878,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"ef1905eb-a31b-4496-b49c-6b976ec6850d","2023-12-01T03:25:22.027+00:00","2025-02-25T19:13:54.369+00:00",[],"Fisiolog%C3%ADa-del-inicio-espont%C3%A1neo-del-trabajo-de-parto",{"references":1049,"title":1051,"doi":1053},{"VOID":1050},"Ratajczak, 2010, Preventing preterm birth: the past limitations and new potential of animal models, Dis Model Mech, 3, 407, 10.1242\u002Fdmm.001701\nCsapo, 1963, Model experiments and clinical trials in the control of pregnancy and parturition, Am J Obstet Gynecol, 85, 359, 10.1016\u002FS0002-9378(16)35446-1\nLiggins, 1974, Parturition in the sheep and the human, Basic Life Sci, 4, 423\nLiggins, 1976, Adrenocortical-related maturational events in the fetus, Am J Obstet Gynecol, 126, 931, 10.1016\u002F0002-9378(76)90680-3\nChallis, 2000, Endocrine and paracrine regulation of birth at term and preterm, Endocr Rev, 21, 514, 10.1210\u002Fer.21.5.514\nKannaki, 2011, Toll-like receptors and their role in animal reproduction, Anim Reprod Sci, 125, 1, 10.1016\u002Fj.anireprosci.2011.03.008\nYoussef, 2009, The role of toll-like receptors (TLR-2 and -4) and triggering receptor expressed on myeloid cells 1 (TREM-1) in human term and preterm labor, Reprod Sci, 16, 843, 10.1177\u002F1933719109336621\nPatni, 2009, Expression and activity of Toll-like receptors 1-9 in the human term placenta and changes associated with labor at term, Biol Reprod, 80, 243, 10.1095\u002Fbiolreprod.108.069252\nRatajczak, 2008, Insights into parturition biology from genetically altered mice, Pediatr Res, 64, 581, 10.1203\u002FPDR.0b013e31818718d2\nMahendroo, 1999, The parturition defect in steroid 5alpha-reductase type 1 knockout mice is due to impaired cervical ripening, Mol Endocrinol, 13, 981, 10.1210\u002Fme.13.6.981\nKimura, 2003, Molecular regulation of the oxytocin receptor in peripheral organs, J Mol Endocrinol, 30, 109, 10.1677\u002Fjme.0.0300109\nGross, 2000, Gene knockout mice in the study of parturition, J Soc Gynecol Investig, 7, 88, 10.1016\u002FS1071-5576(99)00075-1\nCondon, 2004, Surfactant protein secreted by the maturing mouse fetal lung acts as a hormone that signals the initiation of parturition, Proc Natl Acad Sci USA, 101, 4978, 10.1073\u002Fpnas.0401124101\nSamuel, 2005, The relaxin gene-knockout mouse: a model of progressive fibrosis, Ann N Y Acad Sci, 1041, 173, 10.1196\u002Fannals.1282.025\nMitchell, 2009, Are animal models relevant to key aspects of human parturition?, Am J Physiol Regul Integr Comp Physiol, 297, R525, 10.1152\u002Fajpregu.00153.2009\nMcLean, 2001, Corticotrophin-releasing hormone and human parturition, Reproduction, 121, 493, 10.1530\u002Frep.0.1210493\nGolightly, 2011, Endocrine immune interactions in human parturition, Mol Cell Endocrinol, 335, 52, 10.1016\u002Fj.mce.2010.08.005\nZakar, 2007, Progesterone withdrawal: key to parturition, Am J Obstet Gynecol, 196, 289, 10.1016\u002Fj.ajog.2006.09.005\nMesiano, 2011, Progesterone receptors in the human pregnancy uterus: do they hold the key to birth timing?, Reprod Sci, 18, 6, 10.1177\u002F1933719110382922\nMerlino, 2007, Nuclear progesterone receptors in the human pregnancy myometrium: evidence that parturition involves functional progesterone withdrawal mediated by increased expression of progesterone receptor-A, J Clin Endocrinol Metab, 92, 1927, 10.1210\u002Fjc.2007-0077\nMadsen, 2004, Intracrine control of estrogen action in human gestational tissues at parturition, J Soc Gynecol Investig, 11, 213, 10.1016\u002Fj.jsgi.2003.12.003\nCondon, 2003, A decline in the levels of progesterone receptor coactivators in the pregnant uterus at term may antagonize progesterone receptor function and contribute to the initiation of parturition, Proc Natl Acad Sci USA, 100, 9518, 10.1073\u002Fpnas.1633616100\nMesiano, 2002, Progesterone withdrawal and estrogen activation in human parturition are coordinated by progesterone receptor A expression in the myometrium, J Clin Endocrinol Metab, 87, 2924, 10.1210\u002Fjc.87.6.2924\nSmith, 2009, Patterns of plasma corticotropin releasing hormone, progesterone, estradiol, and estriol change and the onset of human labor, J Clin Endocrinol Metab, 94, 2066, 10.1210\u002Fjc.2008-2257\nChristiaens, 2008, Inflammatory processes in preterm and term parturition, J Reprod Immunol, 79, 50, 10.1016\u002Fj.jri.2008.04.002\nGuillot, 2002, Cutting edge: the immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4, J Immunol, 168, 5989, 10.4049\u002Fjimmunol.168.12.5989\nYadav, 2011, Surfactant proteins A and D in pregnancy and parturition, Front Biosci, 3, 291, 10.2741\u002Fe244\nCookson, 2010, NF-kappaB function in the human myometrium during pregnancy and parturition, Histol Histopathol, 25, 945\nMohan, 2007, The effect of mechanical stretch on cyclooxygenase type 2 expression and activator protein-1 and nuclear factor-kappaB activity in human amnion cells, Endocrinology, 148, 1850, 10.1210\u002Fen.2006-1289\nPetraglia, 2010, Neuroendocrine mechanisms in pregnancy and parturition, Endocr Rev, 31, 783, 10.1210\u002Fer.2009-0019\nBowman, 2001, corticotropin releasing hormone-binding protein in primates, Am J Primatol, 53, 123, 10.1002\u002F1098-2345(200103)53:3\u003C123::AID-AJP3>3.0.CO;2-V\nCeccaldi, 2012, Modulation of free corticotrophin-releasing hormone, adrenal and placental steroid hormone levels induced by mifepristone during pregnancy, Fetal Diagn Ther, 32, 267, 10.1159\u002F000338927\nImperatore, 2009, Urocortin 2 stimulates estradiol secretion from cultured human placental cells: an effect mediated by the type 2 corticotrophin releasing hormone (CRH) receptor, Reprod Sci, 16, 551, 10.1177\u002F1933719109332830\nPerkins, 1993, Plasma measurements of corticotrophin releasing hormone-binding protein in normal and abnormal human pregnancy, J Endocrinol, 138, 149, 10.1677\u002Fjoe.0.1380149\nFlorio, 2007, Maternal plasma corticotropin releasing factor (CRF) and CRF-binding protein (CRF-BP) levels in post-term pregnancy: effect of prostaglandin administration, Eur J Endocrinol, 157, 279, 10.1530\u002FEJE-07-0138\nSmith, 1998, corticotropin releasing hormone directly and preferentially stimulates dehydroepiandrosterone sulfate secretion by human fetal adrenal cortical cells, J Clin Endocrinol Metab, 83, 2916, 10.1210\u002Fjc.83.8.2916\nIshimoto, 2011, Development and function of the human fetal adrenal cortex: a key component in the feto-placental unit, Endocr Rev, 32, 317, 10.1210\u002Fer.2010-0001\nSmith, 2007, Corticotrophin releasing hormone and the timing of birth, Front Biosci, 12, 912, 10.2741\u002F2113\nO'Sullivan, 2007, Congenital adrenal hyperplasia due to 21-hydroxylase deficiency is associated with a prolonged gestational age, Arch Dis Child, 92, 690, 10.1136\u002Fadc.2006.112029\nLaurence, 1970, Relationship in anencephaly between the size of the adrenal gland and length of gestation, Arch Dis Child, 45, 148, 10.1136\u002Fadc.45.239.148-a\nGotsch, 2009, The preterm parturition syndrome and its implications for understanding the biology, risk assessment, diagnosis, treatment and prevention of preterm birth, J Matern Fetal Neonatal Med, 22, 5, 10.1080\u002F14767050902860690\nPlunkett, 2011, An evolutionary genomic approach to identify genes involved in human birth timing, PLoS Genet, 7, e1001365, 10.1371\u002Fjournal.pgen.1001365\nRomero, 2006, The use of high-dimensional biology (genomics, transcriptomics, proteomics, and metabolomics) to understand the preterm parturition syndrome, BJOG, 113, 118, 10.1111\u002Fj.1471-0528.2006.01150.x\nSimon, 2011, Association of prenatal and postnatal exposure to lopinavir-ritonavir and adrenal dysfunction among uninfected infants of HIV-infected mothers, JAMA, 306, 70, 10.1001\u002Fjama.2011.915\nAzria, 2009, Pregnancy outcomes in women with HIV type-1 receiving a lopinavir\u002Fritonavir-containing regimen, Antivir Ther, 14, 423, 10.1177\u002F135965350901400302\nPowis, 2011, Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy, J Infect Dis, 204, 506, 10.1093\u002Finfdis\u002Fjir307\nBhumbra, 2007, Exogenous Cushing syndrome with inhaled fluticasone in a child receiving lopinavir\u002Fritonavir, Ann Pharmacother, 41, 1306, 10.1345\u002Faph.1K075\nMolloy, 2011, Cushing's syndrome and adrenal axis suppression in a patient treated with ritonavir and corticosteroid eye drops, AIDS, 25, 1337, 10.1097\u002FQAD.0b013e328347c09c\nFiore, 2006, Antiretroviral therapy-associated modulation of Th1 and Th2 immune responses in HIV-infected pregnant women, J Reprod Immunol, 70, 143, 10.1016\u002Fj.jri.2005.12.001\nChen, 2009, HIV protease inhibitor lopinavir-induced TNF-alpha and IL-6 expression is coupled to the unfolded protein response and ERK signaling pathways in macrophages, Biochem Pharmacol, 78, 70, 10.1016\u002Fj.bcp.2009.03.022\nPasquier, 2008, Les membranes fœtales : développement embryologique, structure et physiopathologie de la rupture prematurée avant terme, J Gynecol Obstet Biol Reprod, 37, 579, 10.1016\u002Fj.jgyn.2007.12.001\nOh, 2005, Progesterone receptor isoform (A\u002FB) ratio of human fetal membranes increases during term parturition, Am J Obstet Gynecol, 193, 1156, 10.1016\u002Fj.ajog.2005.05.071\nLee, 2010, Evidence for a spatial and temporal regulation of prostaglandin-endoperoxide synthase 2 expression in human amnion in term and preterm parturition, J Clin Endocrinol Metab, 95, E86, 10.1210\u002Fjc.2010-0203\nTerzidou, 2011, Labor and inflammation increase the expression of oxytocin receptor in human amnion, Biol Reprod, 84, 546, 10.1095\u002Fbiolreprod.110.086785\nRiley, 1999, Secretion of tissue inhibitors of matrix metalloproteinases by human fetal membranes, decidua and placenta at parturition, J Endocrinol, 162, 351, 10.1677\u002Fjoe.0.1620351\nMcLaren, 1999, Increased incidence of apoptosis in non-labour-affected cytotrophoblast cells in term fetal membranes overlying the cervix, Hum Reprod, 14, 2895, 10.1093\u002Fhumrep\u002F14.11.2895\nYoung, 2002, Immunolocalization of proinflammatory cytokines in myometrium, cervix, and fetal membranes during human parturition at term, Biol Reprod, 66, 445, 10.1095\u002Fbiolreprod66.2.445\nOsman, 2003, Leukocyte density and pro-inflammatory cytokine expression in human fetal membranes, decidua, cervix and myometrium before and during labour at term, Mol Hum Reprod, 9, 41, 10.1093\u002Fmolehr\u002Fgag001\nHertelendy, 2004, Regulation of myometrial smooth muscle functions, Curr Pharm Des, 10, 2499, 10.2174\u002F1381612043383926\nKelly, 2001, Relaxin for cervical ripening and induction of labour, Cochrane Database Syst Rev, CD003103\nMalmstrom, 2007, The importance of fibroblasts in remodelling of the human uterine cervix during pregnancy and parturition, Mol Hum Reprod, 13, 333, 10.1093\u002Fmolehr\u002Fgal117\nGonzalez, 2007, Toll-like receptors in the uterus, cervix, and placenta: is pregnancy an immunosuppressed state?, Am J Obstet Gynecol, 197, 296 e1, 10.1016\u002Fj.ajog.2007.06.021\nStjernholm-Vladic, 2004, Differential regulation of the progesterone receptor A and B in the human uterine cervix at parturition, Gynecol Endocrinol, 18, 41, 10.1080\u002F09513590310001651777\nWord, 2007, Dynamics of cervical remodeling during pregnancy and parturition: mechanisms and current concepts, Semin Reprod Med, 25, 69, 10.1055\u002Fs-2006-956777\nParry, 2007, Relaxin physiology in the female reproductive tract during pregnancy, Adv Exp Med Biol, 612, 34, 10.1007\u002F978-0-387-74672-2_4\nBryant-Greenwood, 2005, Human decidual relaxin and preterm birth, Ann N Y Acad Sci, 1041, 338, 10.1196\u002Fannals.1282.054\nCarbonne, 2002\nAckerman, 2008, Nuclear factor-kappa B regulates inducible prostaglandin E synthase expression in human amnion mesenchymal cells, Biol Reprod, 78, 68, 10.1095\u002Fbiolreprod.107.061663\nGao, 2008, Differential regulation of prostaglandin production mediated by corticotropin releasing hormone receptor type 1 and type 2 in cultured human placental trophoblasts, Endocrinology, 149, 2866, 10.1210\u002Fen.2007-1377\nVercoustre, 2007, Période du terme : le risque périnatal revisité, J Gynecol Obstet Biol Reprod, 36, 663, 10.1016\u002Fj.jgyn.2007.04.007\nTorricelli, 2011, Biochemical and biophysical predictors of the response to the induction of labor in nulliparous postterm pregnancy, Am J Obstet Gynecol, 204, 39 e1, 10.1016\u002Fj.ajog.2010.08.014\nACOG Practice Bulletin No. 107, 2009, Induction of labor, Obstet Gynecol, 114, 386\nDouglas, 1955, Natural and synthetic oxytocin; preliminary report on the use of both for the induction and stimulation of labor, Obstet Gynecol, 6, 254\nKundodyiwa, 2009, Low-dose oral misoprostol for induction of labor: a systematic review, Obstet Gynecol, 113, 374, 10.1097\u002FAOG.0b013e3181945859\nAustin, 2010, Labor induction with intravaginal misoprostol compared with the dinoprostone vaginal insert: a systematic review and metaanalysis, Am J Obstet Gynecol, 202, 624 e1, 10.1016\u002Fj.ajog.2010.03.014\nDawson, 1972, Foley-catheter induction of labor, Br Med J, 4, 492, 10.1136\u002Fbmj.4.5838.492-a\nVaknin, 2010, Foley catheter balloon vs locally applied prostaglandins for cervical ripening and labor induction: a systematic review and metaanalysis, Am J Obstet Gynecol, 203, 418, 10.1016\u002Fj.ajog.2010.04.038\nDelaney, 2010, Labor induction with a Foley balloon inflated to 30mL compared with 60mL: a randomized controlled trial, Obstet Gynecol, 115, 1239, 10.1097\u002FAOG.0b013e3181dec6d0\nMoraes Filho, 2010, A randomized controlled trial comparing vaginal misoprostol versus Foley catheter plus oxytocin for labor induction, Acta Obstet Gynecol Scand, 89, 1045, 10.3109\u002F00016349.2010.499447\nTsatsaris, 2001, Tocolysis with nifedipine or beta-adrenergic agonists: a meta-analysis, Obstet Gynecol, 97, 840, 10.1016\u002FS0029-7844(00)01212-6\nMahajan, 1997, Mifepristone (RU486): a review, Fertil Steril, 68, 967, 10.1016\u002FS0015-0282(97)00189-1\nFiala, 2006, Review of medical abortion using mifepristone in combination with a prostaglandin analogue, Contraception, 74, 66, 10.1016\u002Fj.contraception.2006.03.018\nEquils, 2010, A computer simulation of progesterone and Cox2 inhibitor treatment for preterm labor, PLoS One, 5, e8502, 10.1371\u002Fjournal.pone.0008502",{"ES":1052},"Fisiología del inicio espontáneo del trabajo de parto",{"VOID":1054},"10.1016\u002Fs1283-081x(13)64895-x","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X1364895X",[1057,1072,1084,1096,1108,1120,1131],{"id":1058,"sortIndex":59,"researcher":26,"roles":1059,"affiliations":1060,"properties":1069},"ff754c54-aa8f-4236-9a38-5a380cee3c83",[696],[1061],{"id":26,"sortIndex":36,"affiliation":1062,"properties":26},{"id":1063,"createTime":1064,"updateTime":1064,"relativeEntities":1065,"slug":26,"properties":1066,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"90ffe549-3b45-412d-b47f-2f3cffb2c05d","2023-12-01T03:25:22.098+00:00",[],{"title":1067},{"VI":1068},"Département de gynécologie-obstétrique, Université Paris 7 René Diderot, Centre hospitalier universitaire Beaujon, AP–HP, 100, boulevard du Général-Leclerc, 92110 Clichy, France",{"title":1070},{"VI":1071},"L. Mougel",{"id":1073,"sortIndex":162,"researcher":26,"roles":1074,"affiliations":1075,"properties":1081},"ecf09194-692f-4005-bc63-a05d5a04191f",[696],[1076],{"id":26,"sortIndex":36,"affiliation":1077,"properties":26},{"id":1063,"createTime":1064,"updateTime":1064,"relativeEntities":1078,"slug":26,"properties":1079,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1080},{"VI":1068},{"title":1082},{"VI":1083},"C. Davitian",{"id":1085,"sortIndex":115,"researcher":26,"roles":1086,"affiliations":1087,"properties":1093},"a1855146-d730-41f9-8d77-2a0cbabaf46a",[696],[1088],{"id":26,"sortIndex":36,"affiliation":1089,"properties":26},{"id":1063,"createTime":1064,"updateTime":1064,"relativeEntities":1090,"slug":26,"properties":1091,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1092},{"VI":1068},{"title":1094},{"VI":1095},"M.-C. Lamau",{"id":1097,"sortIndex":36,"researcher":26,"roles":1098,"affiliations":1099,"properties":1105},"3df08d9d-45ec-417b-b4cd-846d9d1bc009",[696],[1100],{"id":26,"sortIndex":36,"affiliation":1101,"properties":26},{"id":1063,"createTime":1064,"updateTime":1064,"relativeEntities":1102,"slug":26,"properties":1103,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1104},{"VI":1068},{"title":1106},{"VI":1107},"P.-F. Ceccaldi",{"id":1109,"sortIndex":135,"researcher":26,"roles":1110,"affiliations":1111,"properties":1117},"8dbfd45b-a743-4b7b-94d8-52b9b2445793",[696],[1112],{"id":26,"sortIndex":36,"affiliation":1113,"properties":26},{"id":1063,"createTime":1064,"updateTime":1064,"relativeEntities":1114,"slug":26,"properties":1115,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1116},{"VI":1068},{"title":1118},{"VI":1119},"D. Luton",{"id":1121,"sortIndex":111,"researcher":26,"roles":1122,"affiliations":1123,"properties":1129},"4cc45b62-2d33-4938-bcc7-36cfecbb4cb3",[696],[1124],{"id":26,"sortIndex":36,"affiliation":1125,"properties":26},{"id":1063,"createTime":1064,"updateTime":1064,"relativeEntities":1126,"slug":26,"properties":1127,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1128},{"VI":1068},{"title":1130},{"VI":921},{"id":1132,"sortIndex":114,"researcher":26,"roles":1133,"affiliations":1134,"properties":1140},"296b8683-e2f1-4f5d-b153-c1fbd7828c4a",[696],[1135],{"id":26,"sortIndex":36,"affiliation":1136,"properties":26},{"id":1063,"createTime":1064,"updateTime":1064,"relativeEntities":1137,"slug":26,"properties":1138,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1139},{"VI":1068},{"title":1141},{"VI":1142},"O. Poujade",{"url":1055,"publisher":1144,"properties":1152},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1145,"slug":662,"properties":1146,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1149,"manageAffiliations":1150,"indexDatabases":1151,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1147,"title":1148},{"VOID":665},{"EN":667},[],[],[],{"volume":1153,"pages":1154},{"VOID":874},{"VOID":1155},"1-13","2013-06-01",{"id":1158,"createTime":1159,"updateTime":1160,"relativeEntities":1161,"slug":1162,"properties":1163,"entityType":688,"verifyStatus":25,"verifyTime":1160,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1170,"fullTextUrl":26,"authors":1171,"publicationType":747,"publisherRelationship":1187,"citationCount":26,"citationInfo":26,"publishDate":1200,"publishYear":1201,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"f8e1d282-8f4d-49e0-906f-f07294e992de","2024-01-26T09:42:18.150+00:00","2024-12-27T09:24:44.506+00:00",[],"Fibromas-uterinos",{"references":1164,"title":1166,"doi":1168},{"VOID":1165},"Abbas, 1997, Uterine rupture during labour after hysteroscopic myomectomy, Cynaecol Endose, 6, 245, 10.1046\u002Fj.1365-2508.1997.970505.x\nAcien, 1996, Abdominal myomectomy: results of a simple operative technique, Fertil Sterin, 65, 41, 10.1016\u002FS0015-0282(16)58025-X\nAharoni, 1988, Uterine myomas and pregnancy, Br I Obstet Gynaecol, 95, 510, 10.1111\u002Fj.1471-0528.1988.tb12807.x\nAndersen, 1998, Factors in fibroid growth, Baillieres Clin Obstet Cynaecol, 12, 225\nAndersen, 1995, Leiomyoma primary cultures have elevated transcriptional response to estrogen compared with autologous myometrial cultures, J Soc Gynecol Invest, 2, 542, 10.1016\u002F1071-5576(94)00053-4\nBaggish, 1989, Hysteroscopic treatment of symptomatic submucous myomata uterine with the Nd:YAG laser, J Gynecol Surg, 15, 17\nBarbot, 1994, Échecs et\u002Fou récidives après myomectomy par voie hystéroscopique, 67\nBernard, 1997, Saline contrastsonohysterography as first-fine investigation for women with uterine bleeding, Ultrasound Obstet Gynecol, 10, 121, 10.1046\u002Fj.1469-0705.1997.10020121.x\nCarr, 1993, An evaluation of the effects of gonadotropin-releasing hormone analoguesand medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double-blind, placebo-controlled, cross-over trial, J Clin Endocrinol Metab, 76, 1217, 10.1210\u002Fjc.76.5.1217\nChegini, 1994, Human uterine tissue throughout the menstrual cycle expresses transforming growth factor-beta 1 (TGF betal ),TGF beta 2, TGF beta 3, and TGF beta type bll receptor messenger ribonucleic acid and protein and contain [125] TGF betal-binding sites, Endocrinology, 135, 439, 10.1210\u002Fen.135.1.439\nCicinelli, 1997, Topical anesthesia for diagnostic hysteroscopy and endometrial biopsy in post menopausal women: a randomised placebo-controlled double-blind study, Br J Obstet Cynaecol, 104, 316, 10.1111\u002Fj.1471-0528.1997.tb11460.x\nCicinelli, 1995, Transabdominal sonohysterography transvaginal sonography and hysteroscopy in the evaluation of submucous myomas, Obstet Gynecol, 85, 42, 10.1016\u002F0029-7844(94)00298-R\nColeman, 1988, Transvaginal and transabdominal sonography: prospective comparison, Radiology, 168, 639, 10.1148\u002Fradiology.168.3.3043545\nCorson, 1991, Resectoscopic myomectomy, Fertil Steril, 55, 1041, 10.1016\u002FS0015-0282(16)54349-0\nCravello, 1995, Hysteroscopic treatment of uterine fibroids, J Gynecol Surg, 11, 227, 10.1089\u002Fgyn.1995.11.227\nDe Aloysio, 1998, Bleeding patterns in recent postmenopausal outpatients with uterine myomas: comparison between two regimens of HRT, Maturitas, 29, 261, 10.1016\u002FS0378-5122(98)00014-0\nDerman, 1991, The long-term effectiveness of hysteroscopic treatment of menorrhagia and leiomyomas, Obstet Gynecol, 77, 591\nDonnez, 1990, Neodymium: YAG laser hysteroscopy in large submucous fibroids, Fertil Steril, 54, 999, 10.1016\u002FS0015-0282(16)53994-6\nDonnez, 2000, Laparoscopie myolysis, Hum Reprod Update, 6, 609, 10.1093\u002Fhumupd\u002F6.6.609\nDubuisson, 1996, Fertility after laparoscopic myomectomy of large intramural myomas: preliminary results, Hum Reprod, 11, 518, 10.1093\u002FHUMREP\u002F11.3.518\nDubuisson, 1997, Laparoscopic myomectomy and myolysis, Curr Opin Obstet Gynecol, 9, 233, 10.1097\u002F00001703-199708000-00004\nDubuisson, 2000, Laparoscopic myomectomy: a current view, Hum Reprod Update, 6, 588, 10.1093\u002Fhumupd\u002F6.6.588\nDubuisson, 1998, Second look after laparoscopic myomectomy, Hum Reprod, 13, 2102, 10.1093\u002Fhumrep\u002F13.8.2102\nDubuisson, 2000, Pregnancy outcome and deliveries following laparoscopic myomectomy, Hum Reprod, 15, 869, 10.1093\u002Fhumrep\u002F15.4.869\nDudiak, 1988, Uterine leiomyomas in the infertile patient: preoperative localization with MR imaging versus US and hystero-salpingography, Radiology, 167, 627, 10.1148\u002Fradiology.167.3.3283833\nEldar-Geva, 1998, Effect of intramural, subserosal, and submucosal uterine fibroids on the outcome of assisted reproductive technology treatment, Fertil Steril, 70, 687, 10.1016\u002FS0015-0282(98)00265-9\nEnglund, 1998, Sex steroid receptors in human myometrium and fibroids: changes during the menstrual cycle and gonadotropin-releasing hormone treatment, J Clin Endocrinol Metab, 83, 4092, 10.1210\u002Fjc.83.11.4092\nFarhi, 1995, Effect of uterine leiomyomata on the results of in-vitro fertilization treatment, Hum Reprod, 10, 2576, 10.1093\u002Foxfordjournals.humrep.a135748\nFriedman, 1995, Does low-dose combination oral contraceptive use affect uterine size or menstrual flow ín premenopausal women with leiomyomas, Obstet Gynecol, 85, 631, 10.1016\u002F0029-7844(95)00007-E\nFriedmann, 1996, Uterine rupture after laparoscopic myomectomy, Acta Obstet Gynecol Scand, 75, 683, 10.3109\u002F00016349609054700\nGiatras, 1999, Fertility after hysteroscopic resection of submucous myomas, J Am Assoc Gynecol Laparosc, 6, 155, 10.1016\u002FS1074-3804(99)80094-2\nGoldenberg, 1995, Outcome of hysteroscopic resection of submucous myomas for infertility, Fertil Steril, 64, 714, 10.1016\u002FS0015-0282(16)57844-3\nGoodwin, 1997, Preliminary experience with uterine artery embolization for uterine fibroids, J Vase Interv Radiol, 8, 517, 10.1016\u002FS1051-0443(97)70603-1\nGoodwin, 1998, Uterine artery embolization for the treatment of uterine fibroids, Curr Opin Obstet Gynecol, 10, 315, 10.1097\u002F00001703-199808000-00006\nGraves, 1933, Tumors of the uterus\nGreogoriou, 1997, Effect of tibolone on posmenopausal women with myoma, Maturitas, 27, 187, 10.1016\u002FS0378-5122(97)00036-4\nHallez, 1995, Single stage total hysteroscopic myomectomies: indications, techniques, and results, Fertil Steril, 63, 703, 10.1016\u002FS0015-0282(16)57469-X\nHofmann, 1984, Binding sites for epidermal growth factor in human uterine tissues and leiomyomas, J Clin Endocrinol Metab, 58, 880, 10.1210\u002Fjcem-58-5-880\nHowe, 1996, Presence of an insulin-like growth factor I autocrine loop predicts uterine fibroid responsiveness to tamoxifen, Cancer Res, 56, 4049\nHucke, 1992, Hysteroscopic resection of submucous myoma, Geburtshilfe Frauenheilkd, 52, 214, 10.1055\u002Fs-2007-1026132\nKarasick, 1992, Imaging of uterine leiomyomas, AJR Am J Roentgenol, 158, 799, 10.2214\u002Fajr.158.4.1546595\nKjerulff, 1996, Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis, J Reprod Med, 41, 483\nLee, 1985, The uterus: in vitro MR-anatomic correlation of normal and abnormal specimens, Radiology, 157, 175, 10.1148\u002Fradiology.157.1.4034962\nLoffer, 1990, Removal of large symptomatic intrauterine growths by the hysteroscopic resectoscope, Obstet Gynecol, 76, 836, 10.1097\u002F00006250-199011000-00023\nLumbiganon, 1995, Protective effect of depolmedroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case-control study, Br J Obstet Cynaecol, 103, 909, 10.1111\u002Fj.1471-0528.1996.tb09911.x\nMais, 1996, Laparoscopie versus abdominal myomectomy: a prospective, randomized trial to evaluate benefits in early outcome, Am J Obstet Gynecol, 174, 654, 10.1016\u002FS0002-9378(96)70445-3\nMarugo, 1989, Estrogen and progesterone receptors in uterine leiomyomas, Acta Obstet Gynecol Scand, 68, 731, 10.3109\u002F00016348909006147\nMatsua, 1997, Increased expression of Bcl2 protein in human uterine leiomyoma and its up-regulation by progesterone, J Clin Endocrinol Metab, 82, 293, 10.1210\u002Fjc.82.1.293\nMayer, 1995, Ultrasonography and MRI of uterine fibroids, Obstet Gynecol Clin North Am, 22, 667, 10.1016\u002FS0889-8545(21)00660-4\nMencaglia, 1986, Diagnostic hysteroscopy today, Acta Eur fertill, 17, 431\nMergui, 1993, Hystéroscopie opératoire et fibromes, Gynécologie, 1, 325\nMurphy, 1993, Regression of uterine leiomyomata in response to the anti-progesterone RU486, J Clin Endocrinol Metab, 76, 513, 10.1210\u002Fjc.76.2.513\nMurphy, 1995, Regression of uterine leiomyomata to the antiprogesterone RU486: dose-response effect, Fertil Steril, 64, 187, 10.1016\u002FS0015-0282(16)57678-X\nNagele, 1997, Randomized placebo controlled trial of mefenamic acid for premedication at outpatient hysteroscopy: a pilotstudy, Br J Obstet Cynaecol, 104, 842, 10.1111\u002Fj.1471-0528.1997.tb12031.x\nNarayan, 1994, Treatment of submucous fibroid and outcome of assisted conception, J Am Assoc Gynecol Laparosc, 1, 307, 10.1016\u002FS1074-3804(05)80793-5\nParazzini, 1988, Epidemiologie characteristics of women with uterine fibroids: a case control study, Obstet Gynecol, 72, 853, 10.1097\u002F00006250-198812000-00008\nParazzini, 1992, Oral contraceptive useand riskofuterinefibroids, Obstet Gynecol, 79, 430, 10.1097\u002F00006250-199203000-00021\nParazzini, 1996, Uterine myomas and smoking results from Italian study, J Reprod Med, 41, 316\nPreutthipan, 1998, Hysteroscopic resection of submucous myoma: a results of 50 procedures, J Med Assoc Thailand, 81, 190\nRamzy, 1998, Uterine myomata and outcome of assisted reproduction, Hum Reprod, 13, 198, 10.1093\u002Fhumrep\u002F13.1.198\nRavina, 1997, Recourse to particular arterial embolization in the treatment of some uterine leiomyoma, Bull Acad Natl, 181, 233\nRavina, 1995, Arterial embolisation to treat uterine myomata, Lancet, 346, 671, 10.1016\u002FS0140-6736(95)92282-2\nRavina, 1994, Embolisation préopératoire des fibromes utérins, Presse Méd, 23, 1540\nReich, 1992, A simple method for ligation with straight and curved needle in operative laparoscopy, Obstet Gynecol, 79, 143\nReidy, 1998, Uterine artery embolization for fibroid disease, Cardiovasc Intervent Radiol, 21, 357, 10.1007\u002Fs002709900280\nRein, 1995, Progesterone: a critical role in the pathogenesis of uterine myomas, Am J Obstet Gynecol, 172, 14, 10.1016\u002F0002-9378(95)90077-2\nSato, 1998, Body fat distribution and uterine leiomyomas, J Epidemiol, 8, 176, 10.2188\u002Fjea.8.176\nSchwarzler, 1998, An evaluation of sonohysterography and diagnostic hysteroscopy for the assessment of intrauterine pathology, Ultrasound Obstet Gynecol, 11, 337, 10.1046\u002Fj.1469-0705.1998.11050337.x\nStovall, 1998, Uterine leiomyomas reduce the efficacy of assisted reproduction cycles: results of a matched follow-up study, Hum Reprod, 13, 192, 10.1093\u002Fhumrep\u002F13.1.192\nTulandi, 1993, Adhesion formation and reproductive outcome after myomectomy and secondlook laparoscopy, Obstei Gynecol, 82, 213\nUgur, 1996, Laparoscopy for adhesion prevention following myomectomy, Int J Gynecol Obstet, 53, 145, 10.1016\u002F0020-7292(95)02644-4\nValle, 1990, Hysteroscopic removal of submucous leiomyomas, J Gynecol Surg, 6, 89, 10.1089\u002Fgyn.1990.6.89\nVan Roessel, 1987, Sonographic investigation of the uterus during artificial uterine cavity distention, JCU J Clin Ultrasound, 15, 439, 10.1002\u002Fjcu.1870150703\nVarasteh, 1999, Pregnancy rates after hysteroscopic polypectomy and myomectomy in infertile women, Obstet Gynecol, 94, 168, 10.1016\u002FS0029-7844(99)00278-1\nVercellini, 1998, Abdominal myomectomy for infertility: a comprehensive review, Hum Reprod, 13, 873, 10.1093\u002Fhumrep\u002F13.4.873\nVercellini, 1999, Determinants of reproductive outcome after abdominal myomectomy for infertility, Fertil Steril, 72, 109, 10.1016\u002FS0015-0282(99)00200-9\nVercellini, 1999, Hysteroscopic myomectomy: long-term effects on menstrual pattern and fertility, Obstet Gynecol, 94, 341, 10.1016\u002FS0029-7844(99)00346-4\nVerkauf, 1992, Myomectomy for fertility enhancement and preservation, Fertil Steril, 58, 1, 10.1016\u002FS0015-0282(16)55128-0\nVij, 1990, Progestin and antiprogestin interactions with progesterone receptors in human myomas, Int J Gynaecol Obstet, 31, 347, 10.1016\u002F0020-7292(90)90913-6\nVikhlyaeva, 1995, Familial predisposition to uterine leiomyomas, Int J Gynaecol Obstet, 51, 127, 10.1016\u002F0020-7292(95)02533-I\nViville, 1997, Distribution of the A and B forms of the progesterone receptor messenger ribonucleic acid and protein in uterine leiomyomata and adjacent myometrium, Hum Reprod, 12, 815, 10.1093\u002Fhumrep\u002F12.4.815\nVollenhoven, 1998, Introduction: the epidemiology of uterine leiomyomas, Baillieres Clin Obstet Gynecol, 12, 169, 10.1016\u002FS0950-3552(98)80059-X\nVollenhoven, 1993, Messenger ribonucleic acid expression of the insulin like growth factors and their binding proteins in uterines fibroids and myometrium, J Clin Endocrinol Metab, 76, 1106, 10.1210\u002Fjc.76.5.1106\nVollenhoven, 1990, Uterine fibroids: a clinical review, Br J Obstet Cynaecol, 97, 285, 10.1111\u002Fj.1471-0528.1990.tb01804.x\nWallach, 1992, Myomectomy, 647\nWamsteker, 1993, Transcervical hysteroscopic resection of submucous fibroids for abnormal uterine bleeding: results regarding the degree of intramural extension, Obstet Gynecol, 82, 736\nWeissman, 1996, Transvaginal ultrasonography in nonpregnant and postmenopausal women, Am Fam Physician, 53, 2065\nZaloudek, 1994, Mesenchymal tumors of the uterus, 487",{"ES":1167},"Fibromas uterinos",{"VOID":1169},"10.1016\u002Fs1283-081x(02)71897-3","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X02718973",[1172],{"id":1173,"sortIndex":36,"researcher":26,"roles":1174,"affiliations":1175,"properties":1184},"0866e30c-27d7-43b6-99de-ef755098efae",[696],[1176],{"id":26,"sortIndex":36,"affiliation":1177,"properties":26},{"id":1178,"createTime":1179,"updateTime":1179,"relativeEntities":1180,"slug":26,"properties":1181,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"164636f5-d903-43bc-8aaa-c5f01cc19780","2024-01-21T05:33:12.399+00:00",[],{"title":1182},{"VI":1183},"Professeur des Universités, praticien hospitalier",{"title":1185},{"VI":1186},"H. Fernandez",{"url":1170,"publisher":1188,"properties":1196},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1189,"slug":662,"properties":1190,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1193,"manageAffiliations":1194,"indexDatabases":1195,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1191,"title":1192},{"VOID":665},{"EN":667},[],[],[],{"volume":1197,"pages":1199},{"VOID":1198},"38",{"VOID":876},"2002-01-01",2002,{"id":1203,"createTime":1204,"updateTime":1204,"relativeEntities":1205,"slug":26,"properties":1206,"entityType":688,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1213,"fullTextUrl":26,"authors":1214,"publicationType":747,"publisherRelationship":1266,"citationCount":26,"citationInfo":26,"publishDate":1278,"publishYear":765,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"e79e628b-a5ca-434e-bd2e-d3bebf37e770","2024-02-11T23:41:12.037+00:00",[],{"references":1207,"title":1209,"doi":1211},{"VOID":1208},"Cantwell, 2011, Saving mothers’ lives: reviewing maternal deaths to make motherhood safer: 2006–2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom, BJOG, 118, 1\nRoyal College of Obstetricians and Gynaecologists. Antepartum haemorrhage. Green-top guidelines 2011;(n°63).\nSaucedo, 2013, Maternal mortality in France, 2007-2009, J Gynecol Obstet Biol Reprod, 42, 613, 10.1016\u002Fj.jgyn.2013.06.011\nKayem, 2014, Management of placenta previa and accreta, J Gynecol Obstet Biol Reprod, 43, 1142, 10.1016\u002Fj.jgyn.2014.10.007\nSentilhes, 2014, Postpartum hemorrhage: guidelines for clinical practice - text of the guidelines (short text), J Gynecol Obstet Biol Reprod, 43, 1170, 10.1016\u002Fj.jgyn.2014.10.009\nGoffinet, 2003, Hémorragies obstétricales du postpartum, 932\nAl Kadri, 2011, Visual estimation versus gravimetric measurement of postpartum blood loss: a prospective cohort study, Arch Gynecol Obstet, 283, 1207, 10.1007\u002Fs00404-010-1522-1\nPatel, 2006, Drape estimation vs. visual assessment for estimating postpartum hemorrhage, Int J Gynaecol Obstet, 93, 220, 10.1016\u002Fj.ijgo.2006.02.014\nToledo, 2007, The accuracy of blood loss estimation after simulated vaginal delivery, Anesth Analg, 105, 1736, 10.1213\u002F01.ane.0000286233.48111.d8\nInVS; IdvsRdCNdEslMMC-jP. www.invs.sante.fr. 2010.\nDarlington, 2012, Effects of in vitro hemodilution, hypothermia and rFVIIa addition on coagulation in human blood, Int J Burns Trauma, 2, 42\nJude, 2004, Hémostase et hypothermie, Sang Thromb Vaiss, 16, 515\nMcLintock, 2011, Obstetric hemorrhage, J Thromb Haemost, 9, 1441, 10.1111\u002Fj.1538-7836.2011.04398.x\nGoffinet, 1995, Practical use of sulprostone in the treatment of hemorrhages during delivery, J Gynecol Obstet Biol Reprod, 24, 209\nRaynal, 2011, Bakri balloon, Gynecol Obstet Fertil, 39, 438, 10.1016\u002Fj.gyobfe.2011.04.001\nBakri, 2001, Tamponade-balloon for obstetrical bleeding, Int J Gynaecol Obstet, 74, 139, 10.1016\u002FS0020-7292(01)00395-2\nVitthala, 2009, Use of Bakri balloon in post-partum haemorrhage: a series of 15 cases, Aust N Z J Obstet Gynaecol, 49, 191, 10.1111\u002Fj.1479-828X.2009.00968.x\nRoyal College of Obstetricians Gynaecologists, 2009\nLeduc, 2009, Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage, J Obstet Gynaecol Can, 31, 980, 10.1016\u002FS1701-2163(16)34329-8\nACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists number 76, October 2006: postpartum hemorrhage. Obstet Gynecol 2006; 108:1039–47.\nLalonde, 2006, Postpartum hemorrhage today: ICM\u002FFIGO initiative 2004-2006, Int J Gynaecol Obstet, 94, 243, 10.1016\u002Fj.ijgo.2006.04.016\nAya, 2014, Anesthetic management of severe or worsening postpartum hemorrhage, J Gynecol Obstet Biol Reprod, 43, 1030, 10.1016\u002Fj.jgyn.2014.10.001\nReccommandations pour la pratique clinique. Hémorragies du postpartum immédiat. J Gynecol Obstet Biol Reprod 2004; 33(Suppl. 8).\nBorgman, 2007, The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital, J Trauma, 63, 805, 10.1097\u002FTA.0b013e3181271ba3\nSher, 1977, Pathogenesis and management of uterine inertia complicating abruptio placentae with consumption coagulopathy, Am J Obstet Gynecol, 129, 164, 10.1016\u002F0002-9378(77)90739-6\nHolcomb, 2008, Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients, Ann Surg, 248, 447, 10.1097\u002FSLA.0b013e318185a9ad\nLevy, 2014, Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy, Transfusion, 54, 1389, 10.1111\u002Ftrf.12431\nHiippala, 1995, Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates, Anesth Analg, 81, 360\nHossain, 2010, Disseminated intravascular coagulation, 394\nCharbit, 2007, The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage, J Thromb Haemost, 5, 266, 10.1111\u002Fj.1538-7836.2007.02297.x\nCortet, 2012, Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial, Br J Anaesth, 108, 984, 10.1093\u002Fbja\u002Faes096\nWikkelso, 2015, Pre-emptive treatment with fibrinogen concentrate for postpartum haemorrhage: randomized controlled trial, Br J Anaesth, 114, 623, 10.1093\u002Fbja\u002Faeu444\nBell, 2010, The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage, Int J Obstet Anesth, 19, 218, 10.1016\u002Fj.ijoa.2009.08.004\nWatson, 2009, Fresh frozen plasma is independently associated with a higher risk of multiple organ failure and acute respiratory distress syndrome, J Trauma, 67, 221, 10.1097\u002FTA.0b013e3181ad5957\nDucloy-Bouthors, 2011, High-dose tranexamic acid reduces blood loss in postpartum haemorrhage, Crit Care, 15, R117, 10.1186\u002Fcc10143\nGungorduk, 2011, Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study, Am J Perinatol, 28, 233, 10.1055\u002Fs-0030-1268238\nMovafegh, 2011, Effect of intravenous tranexamic acid administration on blood loss during and after cesarean delivery, Int J Gynaecol Obstet, 115, 224, 10.1016\u002Fj.ijgo.2011.07.015\nShakur, 2010, The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial, Trials, 11, 40, 10.1186\u002F1745-6215-11-40\nAhonen, 2007, An open non-randomized study of recombinant activated factor VII in major postpartum haemorrhage, Acta Anaesthesiol Scand, 51, 929, 10.1111\u002Fj.1399-6576.2007.01323.x\nAlfirevic, 2007, Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000-2004, Obstet Gynecol, 110, 1270, 10.1097\u002F01.AOG.0000288515.48066.99\nPhillips, 2009, Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry, Anesth Analg, 109, 1908, 10.1213\u002FANE.0b013e3181c039e6\nMannucci, 2007, Prevention and treatment of major blood loss, N Engl J Med, 356, 2301, 10.1056\u002FNEJMra067742\nMcMorrow, 2008, Use of recombinant factor VIIa in massive post-partum haemorrhage, Eur J Anaesthesiol, 25, 293, 10.1017\u002FS0265021507003109\nLe Gouez, 2011, Hémorragie du postpartum, 1\nHuissoud, 2009, Coagulation assessment by rotation thrombelastometry in normal pregnancy, Thromb Haemost, 101, 755, 10.1160\u002FTH08-06-0386\nJohansson, 2009, Thrombelastography and tromboelastometry in assessing coagulopathy in trauma, Scand J Trauma, 17, 45\nOudghiri, 2011, Reference values for rotation thromboelastometry (ROTEM(R)) parameters following non-haemorrhagic deliveries. Correlations with standard haemostasis parameters, Thromb Haemost, 106, 176, 10.1160\u002FTH11-02-0058",{"ES":1210},"Hemorragias obstétricas",{"VOID":1212},"10.1016\u002Fs1283-081x(20)44038-x","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X2044038X",[1215,1230,1242,1254],{"id":1216,"sortIndex":115,"researcher":26,"roles":1217,"affiliations":1218,"properties":1227},"4274695b-f6da-4fcd-b236-44030f5a36ad",[696],[1219],{"id":26,"sortIndex":36,"affiliation":1220,"properties":26},{"id":1221,"createTime":1222,"updateTime":1222,"relativeEntities":1223,"slug":26,"properties":1224,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"53aeca03-5a15-4fa3-9f57-d17563997a00","2024-02-11T23:41:12.073+00:00",[],{"title":1225},{"VI":1226},"Service d’anesthésie, CHU Louis-Mourier, AP–HP, Université Paris-7, 178, rue des Renouillers, 92701 Colombes cedex, France",{"title":1228},{"VI":1229},"S. Nebout",{"id":1231,"sortIndex":114,"researcher":26,"roles":1232,"affiliations":1233,"properties":1239},"2276735c-c0b1-4135-bf31-ae1b54c85d18",[696],[1234],{"id":26,"sortIndex":36,"affiliation":1235,"properties":26},{"id":1221,"createTime":1222,"updateTime":1222,"relativeEntities":1236,"slug":26,"properties":1237,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1238},{"VI":1226},{"title":1240},{"VI":1241},"J. Filippov",{"id":1243,"sortIndex":59,"researcher":26,"roles":1244,"affiliations":1245,"properties":1251},"709705e1-705a-40e3-a636-914bf753774a",[696],[1246],{"id":26,"sortIndex":36,"affiliation":1247,"properties":26},{"id":1221,"createTime":1222,"updateTime":1222,"relativeEntities":1248,"slug":26,"properties":1249,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1250},{"VI":1226},{"title":1252},{"VI":1253},"H. Keita",{"id":1255,"sortIndex":36,"researcher":26,"roles":1256,"affiliations":1257,"properties":1263},"0a5cb27e-d316-4a2b-8698-6a437678bbdf",[696],[1258],{"id":26,"sortIndex":36,"affiliation":1259,"properties":26},{"id":1221,"createTime":1222,"updateTime":1222,"relativeEntities":1260,"slug":26,"properties":1261,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1262},{"VI":1226},{"title":1264},{"VI":1265},"L. Ossé",{"url":1213,"publisher":1267,"properties":1275},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1268,"slug":662,"properties":1269,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1272,"manageAffiliations":1273,"indexDatabases":1274,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1270,"title":1271},{"VOID":665},{"EN":667},[],[],[],{"volume":1276,"pages":1277},{"VOID":759},{"VOID":935},"2020-08-01",{"id":1280,"createTime":1281,"updateTime":1281,"relativeEntities":1282,"slug":26,"properties":1283,"entityType":688,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1290,"fullTextUrl":26,"authors":1291,"publicationType":747,"publisherRelationship":1307,"citationCount":26,"citationInfo":26,"publishDate":1321,"publishYear":1322,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"5a756726-a24c-4418-bd99-1085b02f73c6","2024-01-10T12:38:16.596+00:00",[],{"references":1284,"title":1286,"doi":1288},{"VOID":1285},"Tavassoli, 2003, Tumours of the ovary, 113\nRay-Coquard I, Pujade-Lauraine E, Pautier P, Méeus P, Morice P, Treilleux I, et al. Tumeurs rares de l’ovaire : stratégies thérapeutiques et organisation de la prise en charge. EMC (Elsevier Masson SAS, Paris), Gynécologie, 680-A-50, 2011.\nMcCluggage, 2010, The pathology of and controversial aspects of ovarian borderline tumours, Curr Opin Oncol, 22, 462, 10.1097\u002FCCO.0b013e32833b0dc1\nKurman, 2005, Serous borderline tumours of the ovary, Histopathology, 47, 310, 10.1111\u002Fj.1365-2559.2005.02186.x\nChang, 2008, Prognostic significance of the micropapillary pattern in patients with serous ovarian tumors, Acta Obstet Gynecol Scand, 87, 476, 10.1080\u002F00016340801995640\nUzan, 2011, Prognosis and prognostic factors of the micropapillary pattern in patients treated for stage II and III serous borderline tumors of the ovary, Oncologist, 16, 189, 10.1634\u002Ftheoncologist.2009-0139\nSeidman, 2000, Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators, Hum Pathol, 31, 539, 10.1053\u002Fhp.2000.8048\nRao, 2004, Surgical staging of ovarian low malignant potential tumors, Obstet Gynecol, 104, 261, 10.1097\u002F01.AOG.0000133484.92629.88\nLongacre, 2005, Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or=5-year) follow-up, Am J Surg Pathol, 29, 707, 10.1097\u002F01.pas.0000164030.82810.db\nLesieur, 2011, Prognostic value of lymph node involvement in ovarian serous borderline tumors, Am J Obstet Gynecol, 204, 10.1016\u002Fj.ajog.2010.12.055\nKanat-Pektas, 2011, Complete lymph node dissection: is it essential for the treatment of borderline epithelial ovarian tumors?, Arch Gynecol Obstet, 283, 879, 10.1007\u002Fs00404-010-1539-5\nMcKenney, 2006, Lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors): pathology, prognosis, and proposed classification, Am J Surg Pathol, 30, 614, 10.1097\u002F01.pas.0000194743.33540.e6\nDjordjevic, 2010, Lymph node involvement in ovarian serous tumors of low malignant potential: a clinicopathologic study of thirty-six cases, Am J Surg Pathol, 34, 1, 10.1097\u002FPAS.0b013e3181c0a5ab\nFadare, 2009, Recent developments on the significance and pathogenesis of lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors), Int J Gynecol Cancer, 19, 103, 10.1111\u002FIGC.0b013e3181991a49\nSilverberg, 2000, Histopathologic grading of ovarian carcinoma: a review and proposal, Int J Gynecol Pathol, 19, 7, 10.1097\u002F00004347-200001000-00003\nMalpica, 2004, Grading ovarian serous carcinoma using a two-tier system, Am J Surg Pathol, 28, 496, 10.1097\u002F00000478-200404000-00009\nVang, 2009, Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems, Adv Anat Pathol, 16, 267, 10.1097\u002FPAP.0b013e3181b4fffa\nGilks, 2009, Ovarian carcinoma pathology and genetics: recent advances, Hum Pathol, 40, 1213, 10.1016\u002Fj.humpath.2009.04.017\nMalpica, 2007, Inter-observer and intra-observer variability of a two-tier system for grading ovarian serous carcinoma, Am J Surg Pathol, 31, 1203, 10.1097\u002FPAS.0b013e31803199b0\nVang, 2008, Subdividing ovarian and peritoneal serous carcinoma into moderately- and poorly-differentiated does not have biologic validity based on molecular genetic and in vitro drug resistance data, Am J Surg Pathol, 32, 1667, 10.1097\u002FPAS.0b013e31816fd555\nKindelberger, 2007, Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship, Am J Surg Pathol, 31, 161, 10.1097\u002F01.pas.0000213335.40358.47\nPal, 2005, BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases, Cancer, 104, 2807, 10.1002\u002Fcncr.21536\nRish, 2001, Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer, Am J Hum Genet, 68, 700, 10.1086\u002F318787\nLerwill, 2008, Mucinous tumours of the ovary, Diagn Histopathol, 14, 366, 10.1016\u002Fj.mpdhp.2008.06.010\nRodriguez, 2002, Mucinous tumors of the ovary. A clinicopathologic analysis of 75 borderline tumors (of intestinal type) and carcinomas, Am J Surg Pathol, 26, 139, 10.1097\u002F00000478-200202000-00001\nProvenza, 2008, Anaplastic carcinoma in mucinous ovarian tumors: a clinicopathologic study of 34 cases emphasizing the crucial impact of stage on prognosis, their histologic spectrum, and overlap with sarcoma-like mural nodules, Am J Surg Pathol, 32, 383, 10.1097\u002FPAS.0b013e3181451b93\nRonnett, 1997, Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women, Int J Gynecol Pathol, 16, 1, 10.1097\u002F00004347-199701000-00001\nKim, 2010, Endocervical-like (Mullerian) mucinous borderline tumours of the ovary frequently associated with KRAS mutation, Histopathology, 57, 587, 10.1111\u002Fj.1365-2559.2010.03673.x\nMcMeekin, 1995, Endometrioid adenocarcinoma of the ovary and its relationship to endometriosis, Gynecol Oncol, 59, 81, 10.1006\u002Fgyno.1995.1271\nPetterson, 1991\nWu, 2007, Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt\u002FB-catenin and PI3K\u002FPten signaling pathways, Cancer Cell, 11, 321, 10.1016\u002Fj.ccr.2007.02.016\nKurman, 2011, Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-shifting the paradigm, Hum Pathol, 42, 918, 10.1016\u002Fj.humpath.2011.03.003\nCho, 2009, Ovarian cancer, Annu Rev Pathol, 4, 287, 10.1146\u002Fannurev.pathol.4.110807.092246\nWiegand, 2010, ARID1A mutations in endometriosis-associated ovarian carcinomas, N Engl J Med, 363, 1532, 10.1056\u002FNEJMoa1008433\nCatasus, 2004, Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas, Hum Pathol, 35, 1360, 10.1016\u002Fj.humpath.2004.07.019\nEichhorn, 2002, Mesodermal (mullerian) adenosarcoma of the ovary: a clinic-pathologic analysis of 40 cases and a review of the literature, Am J Surg Pathol, 26, 1243, 10.1097\u002F00000478-200210000-00001\nOliva, 2007, CD10 expression in pure stromal and sex cord-stromal tumors of the ovary: an immunohistochemical analysis of 101 cases, Int J Gynecol Pathol, 26, 359, 10.1097\u002FPGP.0b013e318064511c\nDeLair, 2011, Morphologic spectrum of immunohistochemically characterized clear cell carcinoma of the ovary: a study of 155 cases, Am J Surg Pathol, 35, 36, 10.1097\u002FPAS.0b013e3181ff400e\nMcCluggage, 2008, My approach to and thoughts on the typing of ovarian carcinomas, J Clin Pathol, 61, 152, 10.1136\u002Fjcp.2007.049478\nPrat, 2005, Hereditary ovarian cancer, Hum Pathol, 36, 861, 10.1016\u002Fj.humpath.2005.06.006\nCuatrecasas, 2009, Transitional cell tumors of the ovary. A comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas, Am J Surg Pathol, 33, 556, 10.1097\u002FPAS.0b013e318188b84c\nAl-Agha, 2011, FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary, Am J Surg Pathol, 35, 484, 10.1097\u002FPAS.0b013e31820a406c\nShah, 2009, Mutation of FOXL2 in granulosa-cell tumors of the ovary, N Engl J Med, 360, 2719, 10.1056\u002FNEJMoa0902542\nD’Angelo, 2011, Prognostic significance of FOXL2 mutation and mRNA expression in adult and juvenile granulosa cell tumors of the ovary, Mod Pathol, 24, 1360, 10.1038\u002Fmodpathol.2011.95\nRoth, 2011, Perspectives on pure ovarian stromal neoplasms and tumor-like proliferations of the ovarian stroma, Am J Surg Pathol, 35, e15, 10.1097\u002FPAS.0b013e31820acb89\nYoung, 1985, Ovarian Sertoli-Leydig cell tumor. A clinicopathological analysis of 207 cases, Am J Surg Pathol, 9, 543, 10.1097\u002F00000478-198508000-00001\nZhao, 2009, Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors, Am J Surg Pathol, 33, 354, 10.1097\u002FPAS.0b013e318188373d\nRoth, 2006, Recent advances in the pathology and classification of ovarian germ cell tumors, Int J Gynecol Pathol, 25, 305, 10.1097\u002F01.pgp.0000225844.59621.9d\nScully, 1998\nKleinman, 1993, Primary neuroectodermal tumours of the ovary. A report of 25 cases, Am J Surg Pathol, 17, 764, 10.1097\u002F00000478-199308000-00002\nBuenerd, 2006, Neuroblastome ovarien, Bull Div Fr AIP, 98\nTalerman, 2011, Germ cell tumors of the ovary\nCao, 2009, SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell, Am J Surg Pathol, 33, 894, 10.1097\u002FPAS.0b013e318198177d",{"ES":1287},"Clasificación histopatológica de los tumores ováricos",{"VOID":1289},"10.1016\u002Fs1283-081x(14)68443-5","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X14684435",[1292],{"id":1293,"sortIndex":36,"researcher":26,"roles":1294,"affiliations":1295,"properties":1304},"81e595b1-578f-4e41-a9f2-20a3d5fde68e",[696],[1296],{"id":26,"sortIndex":36,"affiliation":1297,"properties":26},{"id":1298,"createTime":1299,"updateTime":1299,"relativeEntities":1300,"slug":26,"properties":1301,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"7ccd6337-c0b8-480e-8767-eaf4ebcf4345","2024-01-10T12:38:16.607+00:00",[],{"title":1302},{"VI":1303},"Service d’anatomie pathologique, Hôpital européen Georges-Pompidou, 20, rue Leblanc, 75508 Paris cedex 15, France",{"title":1305},{"VI":1306},"M.-A. Le Frère-Belda",{"url":1290,"publisher":1308,"properties":1316},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1309,"slug":662,"properties":1310,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1313,"manageAffiliations":1314,"indexDatabases":1315,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1311,"title":1312},{"VOID":665},{"EN":667},[],[],[],{"volume":1317,"pages":1319},{"VOID":1318},"50",{"VOID":1320},"1-24","2014-09-01",2014,{"id":1324,"createTime":1325,"updateTime":1326,"relativeEntities":1327,"slug":1328,"properties":1329,"entityType":688,"verifyStatus":25,"verifyTime":1326,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1336,"fullTextUrl":26,"authors":1337,"publicationType":747,"publisherRelationship":1367,"citationCount":26,"citationInfo":26,"publishDate":1381,"publishYear":1382,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"43acb280-1c0c-4866-91c0-8788dadce0ac","2024-01-17T13:36:24.521+00:00","2024-12-29T17:06:57.149+00:00",[],"Infecciones-de-transmisi%C3%B3n-sexual",{"references":1330,"title":1332,"doi":1334},{"VOID":1331},"Newman, 2015, Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting, PLoS One, 10, 10.1371\u002Fjournal.pone.0143304\nLa Ruche, 2014, Évolution des résistances du gonocoque aux antibiotiques en France de 2001 à 2012, Bull Epidemiol Hebd, 5, 93\nBulletin des réseaux de surveillance des IST : données au 31 décembre 2013. INVS; novembre 2014.\nBulletin des réseaux de surveillance des infections sexuellement transmissibles (IST) - Rénago, Rénachla et RésIST : données au 31 décembre 2012. Saint-Maurice : InVS, 2015, consultation en ligne : http:\u002F\u002Fwww.invs.sante.fr\u002FDossiers-thematiques\u002FMaladies-infectieuses\u002FVIH-sida-IST\u002FInfections-sexuellement-transmissibles-IST\u002FBulletins-des-reseaux-de-surveillance-des-IST.\nBowen, 2015, Increase in incidence of congenital syphilis—United States, 2012-2014, MMWR Morb Mortal Wkly Rep, 64, 1241, 10.15585\u002Fmmwr.mm6444a3\nBerwald, 2009, Self-administered vaginal swabs are a feasible alternative to physician-assisted cervical swabs for sexually transmitted infection screening in the emergency department, Acad Emerg Med, 16, 360, 10.1111\u002Fj.1553-2712.2009.00359.x\nMiettinen, 1993, Test performance of erythrocyte sedimentation rate and C-reactive protein in assessing the severity of acute pelvic inflammatory disease, Am J Obstet Gynecol, 169, 1143, 10.1016\u002F0002-9378(93)90271-J\nAlthaus, 2012, Towards more robust estimates of the transmissibility of Chlamydia trachomatis, Sex Transm Dis, 39, 402, 10.1097\u002FOLQ.0b013e318248a550\nDavies, 2013, Risk of pelvic inflammatory disease after Chlamydia infection in a prospective cohort of sex workers, Sex Transm Dis, 40, 230, 10.1097\u002FOLQ.0b013e31827b9d75\nDavies, 2014, Heterogeneity in risk of pelvic inflammatory diseases after Chlamydia infection: a population-based study in Manitoba, Canada, J Infect Dis, 210, S549, 10.1093\u002Finfdis\u002Fjiu483\nHammerschlag, 1989, Chlamydial infections, J Pediatr, 114, 727, 10.1016\u002FS0022-3476(89)80128-3\nLanjouw, 2016, 2015 European guideline on the management of Chlamydia trachomatis infections, Int J STD AIDS, 27, 333, 10.1177\u002F0956462415618837\nLand, 2006, Chlamydia antibody testing in subfertile women, Drugs Today, 42, 35\nRenault, 2011, Time to clearance of Chlamydia trachomatis ribosomal RNA in women treated for chlamydial infection, Sex Health, 8, 69, 10.1071\u002FSH10030\nChan, 2016, Extragenital infections caused by Chlamydia trachomatis and Neisseria gonorrhoeae: a review of the literature, Infect Dis Obstet Gynecol, 2016, 5758387, 10.1155\u002F2016\u002F5758387\nTrebach, 2015, Neisseria gonorrhoeae and Chlamydia trachomatis among women reporting extragenital exposures, Sex Transm Dis, 42, 233, 10.1097\u002FOLQ.0000000000000248\nTully, 1981, A newly discovered mycoplasma in the human urogenital tract, Lancet, 1, 1288, 10.1016\u002FS0140-6736(81)92461-2\nTaylor-Robinson, 2011, Mycoplasma genitalium: from chrysalis to multicolored butterfly, Clin Microbiol Rev, 24, 498, 10.1128\u002FCMR.00006-11\nHaggerty, 2011, Mycoplasma genitalium: an emerging cause of pelvic inflammatory disease, Infect Dis Obstet Gynecol, 2006\nOliphant, 2016, Pelvic inflammatory disease associated with Chlamydia trachomatis but not Mycoplasma genitalium in New Zealand, Sex Health, 13, 43, 10.1071\u002FSH14238\nLillis, 2011, Utility of urine, vaginal, cervical, and rectal specimens for detection of Mycoplasma genitalium in women, J Clin Microbiol, 49, 1990, 10.1128\u002FJCM.00129-11\nJernberg, 2008, Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study, Int J STD AIDS, 19, 676, 10.1258\u002Fijsa.2008.008038\nJensen, 2016, 2016 European guideline on Mycoplasma genitalium infections, J Eur Acad Dermatol Venereol, 30, 1650, 10.1111\u002Fjdv.13849\nKokkayil, 2015, Ureaplasma: current perspectives, Indian J Med Microbiol, 33, 205, 10.4103\u002F0255-0857.154850\nZdrodowska-Stefanow, 2006, Ureaplasma urealyticum and Mycoplasma hominis infection in women with urogenital diseases, Adv Med Sci, 51, 250\nKataoka, 2006, Association between preterm birth and vaginal colonization by mycoplasmas in early pregnancy, J Clin Microbiol, 44, 51, 10.1128\u002FJCM.44.1.51-55.2006\nSilver, 2014, Trichomonas vaginalis as a cause of perinatal morbidity: a systematic review and meta-analysis, Sex Transm Dis, 41, 369, 10.1097\u002FOLQ.0000000000000134\nWorld Health Organisation. Sexually transmitted infections management guidelines 1999. http:\u002F\u002Fwww.who.int\u002FHIV_AIDS.\nMark, 2008, Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults, MJ Infect Dis, 198, 1141, 10.1086\u002F591913\nTronstein, 2011, Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection, JAMA, 305, 1441, 10.1001\u002Fjama.2011.420\nBrown, 2003, Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant, JAMA, 289, 203, 10.1001\u002Fjama.289.2.203\nCorey, 2004, Once-daily valacyclovir to reduce the risk of transmission of genital herpes, N Engl J Med, 350, 11, 10.1056\u002FNEJMoa035144\nCentre national de référence des Papillomavirus humains (CNR HPV), Institut Pasteur, 2016.\nDuport, 2004, Le cancer du col de l’utérus : état des connaissances en 2014, Bull Epidemiol Hebd\nMonsonego, 2006\nAlain, 2010, Papillomavirus : les virus et la physiopathologie de l’infection, Med Ther Pediatr, 13, 5\nGavillon, 2010, How did I contract human Papillomavirus (HPV)?, Gynecol Obstet Fertil, 38, 199, 10.1016\u002Fj.gyobfe.2010.01.003\nWiner, 2006, Condom use and the risk of genital human papillomavirus infection in young women, N Engl J Med, 354, 2645, 10.1056\u002FNEJMoa053284\nHuman Papillomaviruses, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans (vol. 90), 2007.\nSyrjänen, 2000\nKoutsky, 1997, Epidemiology of genital human papillomavirus infection, Am J Med, 102, 3, 10.1016\u002FS0002-9343(97)00177-0\nD'Souza, 2007, Case-control study of human papillomavirus and oropharyngeal cancer, N Engl J Med, 356, 1944, 10.1056\u002FNEJMoa065497\nFerenczy, 1995, Epidemiology and clinical pathophysiology of condylomata acuminate, Am J Obstet Gynecol, 172, 1331, 10.1016\u002F0002-9378(95)90399-2\nCox, 2006, The development of cervical cancer and its precursors: what is the role of human papillomavirus infection?, Curr Opin Obstet Gynecol, 18\nWang, 2003, Viral and host factors in human papillomavirus persistence and progression, J Natl Cancer Inst Monogr, 31, 35, 10.1093\u002Foxfordjournals.jncimonographs.a003480\nIversen, 1998, Intraepithelial and invasive squamous cell neoplasia of the vulva: trends in incidence, recurrence, and survival rate in Norway, Obstet Gynecol, 91, 969\nCarter, 1993, Invasive vulvar tumors in young women- a disease of the immunosuppressed?, Gynecol Oncol, 51, 307, 10.1006\u002Fgyno.1993.1295\nANAES. Évaluation de l’intérêt de la recherche des papillomavirus humains (HPV) dans le dépistage des lésions précancéreuses et cancéreuses du col de l’utérus. Mai 2004.\nTamalet, 2016, Genotyping and follow-up of HR-HPV types detected by self-sampling in women from low socioeconomic groups not participating in regular cervical cancer screening in France, J Clin Virol, 78, 102, 10.1016\u002Fj.jcv.2016.02.027\nHaut Conseil de la Santé Publique : Avis sur les infections à HPV des jeunes filles : révision de l’âge de vaccination. Janvier 2013.\nChemlal, 2013\nJoura, 2015, A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women, N Engl J Med, 372, 711, 10.1056\u002FNEJMoa1405044\nHaute Autorité de santé. État des lieux et recommandations pour le dépistage du cancer du col de l’utérus en France. 2010.",{"ES":1333},"Infecciones de transmisión sexual",{"VOID":1335},"10.1016\u002Fs1283-081x(18)89322-5","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X18893225",[1338,1355],{"id":1339,"sortIndex":36,"researcher":26,"roles":1340,"affiliations":1341,"properties":1352},"b7870109-cf54-4554-9ca5-b93c5f621fa4",[696],[1342],{"id":26,"sortIndex":36,"affiliation":1343,"properties":26},{"id":1344,"createTime":1345,"updateTime":1346,"relativeEntities":1347,"slug":1348,"properties":1349,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"06538763-c522-4171-81a3-5c78cfc57486","2024-01-10T16:43:12.676+00:00","2025-06-11T19:24:55.428+00:00",[],"Institut-Fournier-25-boulevard-Saint-Jacques-75014-Paris-France",{"title":1350},{"VI":1351},"Institut Fournier, 25, boulevard Saint-Jacques, 75014 Paris, France",{"title":1353},{"VI":1354},"J.-M. Bohbot",{"id":1356,"sortIndex":115,"researcher":26,"roles":1357,"affiliations":1358,"properties":1364},"c4367592-9996-4f01-972b-815ca8971b61",[696],[1359],{"id":26,"sortIndex":36,"affiliation":1360,"properties":26},{"id":1344,"createTime":1345,"updateTime":1346,"relativeEntities":1361,"slug":1348,"properties":1362,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1363},{"VI":1351},{"title":1365},{"VI":1366},"A. Marchal",{"url":1336,"publisher":1368,"properties":1376},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1369,"slug":662,"properties":1370,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1373,"manageAffiliations":1374,"indexDatabases":1375,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1371,"title":1372},{"VOID":665},{"EN":667},[],[],[],{"volume":1377,"pages":1379},{"VOID":1378},"54",{"VOID":1380},"1-9","2018-06-01",2018,{"id":1384,"createTime":1385,"updateTime":1386,"relativeEntities":1387,"slug":1388,"properties":1389,"entityType":688,"verifyStatus":25,"verifyTime":1386,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1396,"fullTextUrl":26,"authors":1397,"publicationType":747,"publisherRelationship":1437,"citationCount":26,"citationInfo":26,"publishDate":1450,"publishYear":1322,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"2159ecf3-9495-4920-9b54-eba69e499c75","2023-12-05T11:42:26.331+00:00","2025-01-14T18:25:16.733+00:00",[],"Tratamiento-de-las-recidivas-locales-y-locorregionales-del-c%C3%A1ncer-de-cuello-uterino",{"references":1390,"title":1392,"doi":1394},{"VOID":1391},"Resbeut, 2001, Combined brachytherapy and surgery for early carcinoma of the uterine cervix: analysis of extent of surgery on outcome, Int J Radiat Oncol Biol Phys, 50, 873, 10.1016\u002FS0360-3016(01)01602-9\nResbeut, 2001, Carcinoma of the cervix, Br J Cancer, 84, 24, 10.1054\u002Fbjoc.2001.1759\nCarcopino, 2008, Equivalent survival in patients with advanced stage IB-II and III-IVA cervical cancer treated by adjuvant surgery following chemoradiotherapy, Eur J Surg Oncol, 34, 569, 10.1016\u002Fj.ejso.2007.04.006\nHouvenaeghel, 2007, Contribution of surgery in patients with bulky residual disease after chemoradiation for advanced cervical carcinoma, Eur J Surg Oncol, 33, 498, 10.1016\u002Fj.ejso.2006.10.011\n2003, Standard, option et recommandations. Cancer invasif du col utérin. Stade non métastatique, Bull Cancer, 90, 333\nMoutardier, 2004, Surgical resection of locally recurrent cervical cancer: a single institutional 70 patient series, Int J Gynecol Cancer, 14, 846, 10.1111\u002Fj.1048-891X.2004.14519.x\nHouvenaeghel, 2006, Residual pelvic lymph node involvement after concomitant chemoradiation for locally advanced cervical cancer, Gynecol Oncol, 102, 74, 10.1016\u002Fj.ygyno.2005.11.037\nHouvenaeghel, 1991, Locoregional extension of advanced cancer of the uterine cervix:prospective evaluation of results of clinical examination, endocavitary ultrasonography, TDM, MRI and histology, Bull Cancer, 78, 969\nHouvenaeghel, 1994, Pelvic staging of advanced and recurrent gynecologic cancers: contribution of endosonography, Gynecol Oncol, 55, 393, 10.1006\u002Fgyno.1994.1312\nBourguet, 2006, 2005 monitoring report: use of positron emission tomography with fluorodeoxyglucose in the management of patients with breast cancer, ovarian cancer, and uterine cancer, Gynecol Obstet Fertil, 34, 437\nBourguet, 2006, Synthesis bulletin of 2005 surveillance. Clinical practice recommendations: the use of PET-FDG in cancers of the breast, ovary and uterus, Bull Cancer, 93, 385\nLeblanc, 2011, Accuracy of 18-fluoro-2-deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma, Ann Surg Oncol, 18, 2302, 10.1245\u002Fs10434-011-1583-9\nHouvenaeghel, 2005, Locoregional recurrence of cervical and endometrial carcinoma: role of surgical resection, Bull Cancer, 92, 782\nJauffret, 2011, Robot-assisted laparoscopy in the management of recurrent pelvic cancer, Gynecol Obstet Fertil, 39, 674, 10.1016\u002Fj.gyobfe.2011.07.021\nLambaudie, 2010, Robotically-assisted laparoscopic anterior pelvic exenteration for recurrent cervical cancer: report of three first cases, Gynecol Oncol, 116, 582, 10.1016\u002Fj.ygyno.2009.10.083\nMagrina, 1990, Types of pelvic exenterations: a reappraisal, Gynecol Oncol, 37, 363, 10.1016\u002F0090-8258(90)90368-U\nMagrina, 1997, Pelvic exenterations: supralevator, infralevator, and with vulvectomy, Gynecol Oncol, 64, 130, 10.1006\u002Fgyno.1996.4532\nHockel, 1996, Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall, Cancer, 77, 1918, 10.1002\u002F(SICI)1097-0142(19960501)77:9\u003C1918::AID-CNCR24>3.0.CO;2-1\nCaceres, 2008, Extended pelvic resections for recurrent uterine and cervical cancer: out-of-the-box surgery, Int J Gynecol Cancer, 18, 1139, 10.1111\u002Fj.1525-1438.2007.01140.x\nClasse, 2006, Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome: results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer), Gynecol Oncol, 102, 523, 10.1016\u002Fj.ygyno.2006.01.022\nMotton, 2010, Results of surgery after concurrent chemoradiotherapy in advanced cervical cancer: comparison of extended hysterectomy and extrafascial hysterectomy, Int J Gynecol Cancer, 20, 268, 10.1111\u002FIGC.0b013e3181c9e385\nHouvenaeghel, 2006, Long-term survival after concomitant chemoradiotherapy prior to surgery in advanced cervical carcinoma, Gynecol Oncol, 100, 338, 10.1016\u002Fj.ygyno.2005.08.047\nLeguevaque, 2011, Completion surgery or not after concurrent chemoradiotherapy for locally advanced cervical cancer?, Eur J Obstet Gynecol Reprod Biol, 155, 188, 10.1016\u002Fj.ejogrb.2010.11.016\nPeters, 2000, Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix, J Clin Oncol, 18, 1606, 10.1200\u002FJCO.2000.18.8.1606\nRose, 1999, Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer, N Engl J Med, 340, 1144, 10.1056\u002FNEJM199904153401502\nMorris, 1999, Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer, N Engl J Med, 340, 1137, 10.1056\u002FNEJM199904153401501\nGreen, 2001, Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis, Lancet, 358, 781, 10.1016\u002FS0140-6736(01)05965-7\nWhitney, 1999, Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study, J Clin Oncol, 17, 1339, 10.1200\u002FJCO.1999.17.5.1339\nBladou, 1995, Incidence and management of major urinary complications after pelvic exenteration for gynecological malignancies, J Surg Oncol, 58, 91, 10.1002\u002Fjso.2930580204\nKarsenty, 2005, Long-term follow-up of continent urinary diversion after pelvic exenteration for gynecologic malignancies, Gynecol Oncol, 97, 524, 10.1016\u002Fj.ygyno.2004.12.009\nHouvenaeghel, 2004, Major complications of urinary diversion after pelvic exenteration for gynecologic malignancies: a 23-year mono-institutional experience in 124 patients, Gynecol Oncol, 92, 680, 10.1016\u002Fj.ygyno.2003.11.003\nBladou, 1996, The Miami pouch: a reliable continent urinary diversion after pelvic exenteration, Prog Urol, 6, 217\nAngioli, 1998, Urinary complications of Miami pouch: trend of conservative management, Am J Obstet Gynecol, 179, 343, 10.1016\u002FS0002-9378(98)70362-X\nGolimbu, 1973, Electrolyte disturbances in jejunal urinary diversion, Urology, 1, 432, 10.1016\u002F0090-4295(73)90374-9\nEdington, 1988, Management of the surgically traumatized, irradiated, and infected pelvis, Surgery, 103, 690\nSoper, 1989, Pelvic exenteration: factors associated with major surgical morbidity, Gynecol Oncol, 35, 93, 10.1016\u002F0090-8258(89)90020-6\nRoberts, 1987, Major morbidity after pelvic exenteration: a seven-year experience, Obstet Gynecol, 69, 617\nOrr, 1982, Urinary diversion in patients undergoing pelvic exenteration, Am J Obstet Gynecol, 142, 883, 10.1016\u002FS0002-9378(16)32536-4\nGilchrist, 1950, Construction of a substitute bladder and urethra, Surg Gynecol Obstet, 90, 752\nMansson, 1984, The continent caecal reservoir for urine, Scand J Urol Nephrol Suppl, 85, 1\nRowland, 1987, Indiana continent urinary reservoir, J Urol, 137, 1136, 10.1016\u002FS0022-5347(17)44428-4\nLockhart, 1987, Remodeled right colon: an alternative urinary reservoir, J Urol, 138, 730, 10.1016\u002FS0022-5347(17)43355-6\nBejany, 1988, Stapled and nonstapled tapered distal ileum for construction of a continent colonic urinary reservoir, J Urol, 140, 491, 10.1016\u002FS0022-5347(17)41699-5\nPenalver, 1989, Continent urinary diversion in gynecologic oncology, Gynecol Oncol, 34, 274, 10.1016\u002F0090-8258(89)90159-5\nPenalver, 1994, Complications of the ileocolonic continent urinary reservoir (Miami pouch), Gynecol Oncol, 52, 360, 10.1006\u002Fgyno.1994.1062\nSkinner, 1987, An update on the Kock pouch for continent urinary diversion, Urol Clin North Am, 14, 789, 10.1016\u002FS0094-0143(21)01561-5\nLieskovsky, 1987, Management of late complications of the Kock pouch form of urinary diversion 19, J Urol, 137, 1146, 10.1016\u002FS0022-5347(17)44430-2\nRowland, 1987, Alternative techniques for a continent urinary reservoir, Urol Clin North Am, 14, 797, 10.1016\u002FS0094-0143(21)01562-7\nSkinner, 1987, Continuing experience with the continent ileal reservoir (Kock pouch) as an alternative to cutaneous urinary diversion: an update after 250 cases 21, J Urol, 137, 1140, 10.1016\u002FS0022-5347(17)44429-6\nGolomb, 1989, Complications of bladder substitution and continent urinary diversion, Urology, 34, 329, 10.1016\u002F0090-4295(89)90435-4\nArai, 1991, Afferent nipple valve malfunction caused by anchoring collar: an unexpected late complication of the Kock continent ileal reservoir, J Urol, 145, 29, 10.1016\u002FS0022-5347(17)38238-1\nWebster, 1992, Continent urinary diversion, Important Adv Oncol, 137\nSalom, 2004, Continent ileocolonic urinary reservoir (Miami pouch): the University of Miami experience over 15 years, Am J Obstet Gynecol, 190, 994, 10.1016\u002Fj.ajog.2004.01.023\nRamirez, 2002, Functional outcomes and complications of continent urinary diversions in patients with gynecologic malignancies, Gynecol Oncol, 85, 285, 10.1006\u002Fgyno.2002.6594\nPenalver, 1998, Management of early and late complications of ileocolonic continent urinary reservoir (Miami pouch), Gynecol Oncol, 69, 185, 10.1006\u002Fgyno.1998.4981\nAngioli, 2003, Continent urinary diversion and low colorectal anastomosis after pelvic exenteration. Quality of life and complication risk, Crit Rev Oncol Hematol, 48, 281, 10.1016\u002FS1040-8428(03)00126-4\nTurrini, 2006, Perineal small bowel fistula after pelvic exenteration for cancer: technical guidelines for perineal fistula, Ann Surg Oncol, 13, 1622, 10.1245\u002Fs10434-006-9117-6\nFerron, 2003, Vaginal reconstruction after pelvic exenteration: when and which techniques?, Bull Cancer, 90, 435\nHannoun-Levi, 1997, Preliminary results of a phase I\u002FII study of post-operative high-dose rate brachytherapy for advanced or recurrent pelvic tumours, Eur J Surg Oncol, 23, 532, 10.1016\u002FS0748-7983(97)93109-7\nHouvenaeghel, 2005, Rectus abdominis myocutaneous flap in radical oncopelvic surgery: a safe and useful procedure, Eur J Surg Oncol, 31, 1185, 10.1016\u002Fj.ejso.2005.07.004\nBeitler, 1997, Pelvic exenteration for cervix cancer: would additional intraoperative interstitial brachytherapy improve survival?, Int J Radiat Oncol Biol Phys, 38, 143, 10.1016\u002FS0360-3016(96)00585-8\nMoutardier, 2003, Colorectal function preservation in posterior and total supralevator exenteration for gynecologic malignancies: an 89-patient series, Gynecol Oncol, 89, 155, 10.1016\u002FS0090-8258(03)00069-6\nHouvenaeghel, 2009, Modified posterior pelvic exenteration for ovarian cancer, Int J Gynecol Cancer, 19, 968, 10.1111\u002FIGC.0b013e3181a7f38b\nBrunschwig, 1948, Complete excision of pelvic viscera for advanced carcinoma; a one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy, Cancer, 1, 177, 10.1002\u002F1097-0142(194807)1:2\u003C177::AID-CNCR2820010203>3.0.CO;2-A\nBrunschwig, 1965, What are the indications and results of pelvic exenteration?, JAMA, 194, 274, 10.1001\u002Fjama.194.3.274\nAverette, 1984, Pelvic exenteration: a 15-year experience in a general metropolitan hospital, Am J Obstet Gynecol, 150, 179, 10.1016\u002FS0002-9378(84)80013-7\nKraybill, 1988, Total pelvic exenteration as a therapeutic option in advanced malignant disease of the pelvis, Surg Gynecol Obstet, 166, 259\nJakowatz, 1985, Complications of pelvic exenteration, Arch Surg, 120, 1261, 10.1001\u002Farchsurg.1985.01390350043009\nAnthopoulos, 1989, Pelvic exenteration: a morbidity and mortality analysis of a seven-year experience, Gynecol Oncol, 35, 219, 10.1016\u002F0090-8258(89)90047-4\nHouvenaeghel, 1999, Recurrences of pelvic cancers. Pelvic reconstruction: when, how, why?, Ann Chir, 53, 902\nColeman, 1994, Radical hysterectomy for recurrent carcinoma of the uterine cervix after radiotherapy, Gynecol Oncol, 55, 29, 10.1006\u002Fgyno.1994.1242\nRutledge, 1994, Conservative surgery for recurrent or persistent carcinoma of the cervix following irradiation: is exenteration always necessary?, Gynecol Oncol, 5",{"ES":1393},"Tratamiento de las recidivas locales y locorregionales del cáncer de cuello uterino",{"VOID":1395},"10.1016\u002Fs1283-081x(14)69285-7","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X14692857",[1398,1425],{"id":1399,"sortIndex":36,"researcher":26,"roles":1400,"affiliations":1401,"properties":1422},"a0f456e3-7a6f-4e6e-bca7-a5876039bad8",[696],[1402,1410],{"id":26,"sortIndex":36,"affiliation":1403,"properties":26},{"id":1404,"createTime":1405,"updateTime":1405,"relativeEntities":1406,"slug":26,"properties":1407,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"fe1b8b02-a2ed-4378-8a7d-dce031388bf7","2023-12-05T11:42:26.351+00:00",[],{"title":1408},{"VI":1409},"Institut Paoli Calmettes, 232, boulevard de Sainte-Marguerite, BP 156, 13273 Marseille cedex 09, France",{"id":1411,"sortIndex":115,"affiliation":1412,"properties":1421},"153f2e7f-3b4f-48a9-bf8c-7d84f84ed006",{"id":1413,"createTime":1414,"updateTime":1415,"relativeEntities":1416,"slug":1417,"properties":1418,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"059158c6-c9c0-43df-8900-ab82eb08f91f","2023-12-05T11:42:26.342+00:00","2025-06-11T18:44:05.122+00:00",[],"Universit%C3%A9-de-la-M%C3%A9diterran%C3%A9e-Jardin-du-Pharo-58-boulevard-Charles-Livon-13284-Marseille-cedex-07-France",{"title":1419},{"VI":1420},"Université de la Méditerranée, Jardin du Pharo, 58, boulevard Charles-Livon, 13284 Marseille cedex 07, France",{},{"title":1423},{"VI":1424},"G. Houvenaeghel",{"id":1426,"sortIndex":115,"researcher":26,"roles":1427,"affiliations":1428,"properties":1434},"f5b2448a-82e6-450e-9731-e8bb1b90997a",[696],[1429],{"id":26,"sortIndex":36,"affiliation":1430,"properties":26},{"id":1404,"createTime":1405,"updateTime":1405,"relativeEntities":1431,"slug":26,"properties":1432,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1433},{"VI":1409},{"title":1435},{"VI":1436},"E. Lambaudie",{"url":1396,"publisher":1438,"properties":1446},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1439,"slug":662,"properties":1440,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1443,"manageAffiliations":1444,"indexDatabases":1445,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1441,"title":1442},{"VOID":665},{"EN":667},[],[],[],{"volume":1447,"pages":1448},{"VOID":1318},{"VOID":1449},"1-10","2014-12-01"]